<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="rapid-odp" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">rapid-odp</book-part-id>
      <title-group>
        <title><italic toggle="yes">ATP1A3-</italic>Related Neurologic Disorders</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Brashear</surname>
            <given-names>Allison</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Professor and Chair, Department of Neurology<break/>Wake Forest University School of Medicine<break/>Winston-Salem, North Carolina</aff>
          <email>abrashea@wakehealth.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sweadner</surname>
            <given-names>Kathleen J</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Associate Professor of Cellular and Molecular Physiology, Department of Surgery<break/>Massachusetts General Hospital<break/>Boston, Massachusetts</aff>
          <email>sweadner@helix.mgh.harvard.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Cook</surname>
            <given-names>Jared F</given-names>
          </name>
          <degrees>MA</degrees>
          <aff>Project Manager, Department of Neurology<break/>Wake Forest University School of Medicine<break/>Winston-Salem, North Carolina</aff>
          <email>jarcook@wakehealth.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Swoboda</surname>
            <given-names>Kathryn J</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Professor, Department of Neurology<break/>University of Utah School of Medicine<break/>Salt Lake City, Utah</aff>
          <email>swoboda@genetics.utah.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ozelius</surname>
            <given-names>Laurie</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Associate Professor, Departments of Genetics and Genomic Sciences and Neurology<break/>Icahn School of Medicine at Mount Sinai<break/>New York, New York</aff>
          <email>laurie.ozelius@mssm.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>7</day>
          <month>2</month>
          <year>2008</year>
        </date>
        <date date-type="updated">
          <day>6</day>
          <month>11</month>
          <year>2014</year>
        </date>
        <date date-type="revised">
          <day>13</day>
          <month>9</month>
          <year>2012</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="arsacs" document-type="chapter">ARSACS</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="cutis-laxa" document-type="chapter"><italic toggle="yes">ATP6V0A2</italic>-Related Cutis Laxa</related-object>
      <abstract id="rapid-odp.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>The spectrum of <italic toggle="yes">ATP1A3</italic>-related neurologic disorders includes rapid-onset dystonia-parkinsonism (RDP), alternating hemiplegia of childhood (AHC), and <italic toggle="yes">c</italic>erebellar ataxia, <italic toggle="yes">a</italic>reflexia, <italic toggle="yes">p</italic>es cavus, <italic toggle="yes">o</italic>ptic atrophy, and <italic toggle="yes">s</italic>ensorineural hearing loss (CAPOS) syndrome. While early reports emphasized the distinctness of RDP and AHC, it is increasingly evident that these conditions represent a spectrum related to mutation of <italic toggle="yes">ATP1A3</italic>. Because only ten individuals from three families and one individual with a <italic toggle="yes">de novo</italic> pathogenic variant have been described with CAPOS syndrome to date, its phenotype is less defined; however, some features overlap with RDP and AHC as well.</p>
          <list list-type="bullet">
            <list-item>
              <p>RDP is characterized by abrupt onset of dystonia with parkinsonism (primarily bradykinesia and postural instability); a clear rostrocaudal (face&#x0003e;arm&#x0003e;leg) topological gradient of involvement; bulbar involvement; and absence of response to an adequate trial of L-dopa therapy. Often fever, physiologic stress, or alcoholic binges trigger the onset of symptoms. After their initial appearance, symptoms often stabilize with little improvement; occasionally second episodes occur with abrupt worsening of symptoms. Anxiety, depression, and seizures have been reported. Age of onset is four to 55 years.</p>
            </list-item>
            <list-item>
              <p>AHC is a complex neurodevelopmental syndrome most frequently manifesting in infancy or early childhood with paroxysmal episodic neurologic dysfunction including alternating hemiparesis or dystonia, quadriparesis, seizure-like episodes, and oculomotor abnormalities. Episodes can last for minutes, hours, days, or even weeks. Remission of symptoms occurs with sleep and immediately after awakening. Over time, persistent neurologic deficits develop in the majority of those affected, including oculomotor apraxia, ataxia, choreoathetosis, dystonia, parkinsonism, and cognitive and behavioral dysfunction; more than 50% develop epilepsy in addition to their episodic movement disorder phenotype.</p>
            </list-item>
            <list-item>
              <p>CAPOS syndrome (a mnemonic for cerebellar ataxia, areflexia, optic atrophy, and sensorineural hearing loss) is characterized by episodes of ataxic encephalopathy and/or weakness after a febrile illness. Onset is between ages six months and five years. Some acute symptoms resolve; disease progression and severity vary.</p>
            </list-item>
          </list>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Diagnosis of an <italic toggle="yes">ATP1A3</italic>-related neurologic disorder is suspected in an individual with the classic clinical features of RDP, AHC, or CAPOS syndrome and confirmed by detection of a heterozygous pathogenic variant in <italic toggle="yes">ATP1A3.</italic></p>
        </sec>
        <sec>
          <title>Management</title>
          <p>
            <italic toggle="yes">Treatment of manifestations:</italic>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>RDP<italic toggle="yes">.</italic> High-dose benzodiazepines in some, and standard treatment for seizures, dysphagia, and depression and anxiety.</p>
            </list-item>
            <list-item>
              <p>AHC. Avoiding triggers; reducing the frequency and/or severity of recurrent paroxysmal episodes with medication (e.g., flunarizine, topiramate) or by sleep (either natural or induced with medications such as benzodiazepines or chloral hydrate). Standard treatment of seizures.</p>
            </list-item>
            <list-item>
              <p>CAPOS syndrome. Treatment of manifestations apart from hearing and visual aids has not been reported. Management includes physical therapy to prevent contractures and monitoring of swallow function to reduce the risk for aspiration.</p>
            </list-item>
          </list>
          <p>
            <italic toggle="yes">Agents/circumstances to avoid:</italic>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>RDP. Triggers including alcohol, fever, psychological stress, excessive exercise.</p>
            </list-item>
            <list-item>
              <p>AHC. Triggers including psychological stress/excitement; environmental stressors (e.g., bright light, excessive heat or cold, excessive sound, crowds); water exposure (e.g., bathing, swimming); certain foods or odors (e.g., chocolate, food dyes, missed meals); excessive or atypically strenuous exercise; illness; irregular sleep (missing a nap, delayed bedtime).</p>
            </list-item>
            <list-item>
              <p>CAPOS syndrome. Febrile illness</p>
            </list-item>
          </list>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p><italic toggle="yes">ATP1A3</italic>-related neurologic disorders are inherited in an autosomal dominant manner. <italic toggle="yes">ATP1A3</italic> pathogenic variants may be inherited or <italic toggle="yes">de novo</italic>. In AHC, <italic toggle="yes">de novo</italic> pathogenic variants are more common than inherited; in both RDP and CAPOS syndrome both inherited and <italic toggle="yes">de novo</italic> pathogenic variants have been observed. Each child of an individual with an <italic toggle="yes">ATP1A3</italic>-related neurologic disorder has a 50% chance of inheriting the <italic toggle="yes">ATP1A3</italic> pathogenic variant. Prenatal testing for pregnancies at increased risk is possible if the <italic toggle="yes">ATP1A3</italic> pathogenic variant in the family is known.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="rapid-odp.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="rapid-odp.Tc" orientation="portrait" position="anchor">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_rapid-odp.Tc_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">ATP1A3</italic>-Related Neurologic Disorders: Included Phenotypes&#x000a0;<sup>1</sup></th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_rapid-odp.Tc_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Rapid-onset dystonia-parkinsonism (RDP)</p></list-item><list-item><p>Alternating hemiplegia of childhood (AHC)</p></list-item><list-item><p>Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS) syndrome</p></list-item></list>
</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>For synonyms and outdated names see <xref ref-type="sec" rid="rapid-odp.Nomenclature">Nomenclature</xref>.</p>
            </fn>
            <fn id="rapid-odp.TF.c.1">
              <label>1. </label>
              <p>For other genetic causes of these phenotypes see <xref ref-type="sec" rid="rapid-odp.Differential_Diagnosis">Differential Diagnosis</xref>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="rapid-odp.Diagnosis">
        <title>Diagnosis</title>
        <sec id="rapid-odp.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p><bold>Rapid-onset dystonia-parkinsonism (RDP)</bold> should be considered in individuals with the following clinical features [<xref ref-type="bibr" rid="rapid-odp.REF.brashear.2007.828">Brashear et al 2007</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>Abrupt onset of dystonia with features of parkinsonism over a few minutes to 30 days [<xref ref-type="bibr" rid="rapid-odp.REF.dobyns.1993.2596">Dobyns et al 1993</xref>]</p>
            </list-item>
            <list-item>
              <p>A clear rostrocaudal (face&#x0003e;arm&#x0003e;leg) topological gradient of involvement</p>
            </list-item>
            <list-item>
              <p>Prominent bulbar findings on examination</p>
            </list-item>
            <list-item>
              <p>Absence of response to an adequate trial of L-dopa therapy (e.g., carbidopa/levodopa 25/100 one pill 3x/day)</p>
            </list-item>
            <list-item>
              <p>Family history consistent with autosomal dominant inheritance, although <italic toggle="yes">de novo</italic> pathogenic variants are common [<xref ref-type="bibr" rid="rapid-odp.REF.anselm.2009.400">Anselm et al 2009</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.blancoarias.2009.2370">Blanco-Arias et al 2009</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.tarsy.2010.2213">Tarsy et al 2010</xref>].</p>
            </list-item>
          </list>
          <p>Additional features that suggest RDP:</p>
          <list list-type="bullet">
            <list-item>
              <p>Minimal or no tremor at onset</p>
            </list-item>
            <list-item>
              <p>Occasional mild limb dystonia prior to the abrupt onset of dystonia</p>
            </list-item>
            <list-item>
              <p>Triggers (e.g., running, childbirth, emotional stress, or alcoholic binges) associated with the abrupt onset of symptoms</p>
            </list-item>
            <list-item>
              <p>Stabilization of symptoms within a month</p>
            </list-item>
            <list-item>
              <p>Rare "second onsets" or abrupt worsening of symptoms later in life</p>
            </list-item>
            <list-item>
              <p>Minimal improvement overall, but with limited improvement in gait</p>
            </list-item>
          </list>
          <p>Non-motor features of RDP:</p>
          <list list-type="bullet">
            <list-item>
              <p>Cognitive impairment [<xref ref-type="bibr" rid="rapid-odp.REF.cook.2014.344">Cook et al 2014</xref>]</p>
            </list-item>
            <list-item>
              <p>Psychiatric illnesses including psychosis [<xref ref-type="bibr" rid="rapid-odp.REF.brashear.2012a.1168">Brashear et al 2012a</xref>]</p>
            </list-item>
          </list>
          <p>Although most people with RDP present with at least some of these typical features, exceptions have included:</p>
          <list list-type="bullet">
            <list-item>
              <p>Onset in infancy</p>
            </list-item>
            <list-item>
              <p>Onset after age 60 years</p>
            </list-item>
            <list-item>
              <p>Onset of seizures after appearance of motor symptoms</p>
            </list-item>
          </list>
          <p><bold>Alternating hemiplegia of childhood (AHC).</bold> Diagnostic criteria for a clinically definite diagnosis of AHC (see Note):</p>
          <list list-type="bullet">
            <list-item>
              <p>Onset of symptoms before age 18 months</p>
            </list-item>
            <list-item>
              <p>Paroxysmal disturbances including tonic or dystonic spells, oculomotor abnormalities, and autonomic phenomena during hemiplegic episodes or in isolation</p>
            </list-item>
            <list-item>
              <p>Repeated attacks of hemiplegia involving either side of the body</p>
            </list-item>
            <list-item>
              <p>Episodes of bilateral hemiplegia or quadriplegia either at the onset or as generalization of a hemiplegic episode</p>
            </list-item>
            <list-item>
              <p>Immediate disappearance of symptoms upon sleeping (symptoms may later resume after waking)</p>
            </list-item>
            <list-item>
              <p>Evidence of developmental delay and neurologic abnormalities including choreoathetosis, dystonia, and/or ataxia</p>
            </list-item>
          </list>
          <p>Note: Diagnostic criteria assume that (1) initial diagnostic workup has not shown evidence of an alternative etiology (e.g., treatable metabolic disorder); (2) brain MRI is normal or with nonspecific features not identifying an alternative pathophysiology (e.g., vascular disease such as moyamoya); and (3) EEG during prolonged episodes of hemiplegia or dystonia does not provide an alternative explanation for episodes.</p>
          <p>Other associated features in some individuals with AHC:</p>
          <list list-type="bullet">
            <list-item>
              <p>Tremor</p>
            </list-item>
            <list-item>
              <p>Recurrent apnea</p>
            </list-item>
            <list-item>
              <p>Respiratory distress</p>
            </list-item>
            <list-item>
              <p>Oxygen desaturation during episodes of neurologic dysfunction</p>
            </list-item>
          </list>
          <p><bold>CAPOS syndrome.</bold> Suggestive findings:</p>
          <list list-type="bullet">
            <list-item>
              <p>Episodes of ataxic encephalopathy and/or weakness after a febrile illness</p>
            </list-item>
            <list-item>
              <p>Onset in infancy or childhood</p>
            </list-item>
            <list-item>
              <p>Cerebellar ataxia</p>
            </list-item>
            <list-item>
              <p>Areflexia</p>
            </list-item>
            <list-item>
              <p>Progressive optic atrophy</p>
            </list-item>
            <list-item>
              <p>Progressive sensorineural hearing loss</p>
            </list-item>
          </list>
          <p>Other associated features in some individuals with CAPOS syndrome:</p>
          <list list-type="bullet">
            <list-item>
              <p>Abnormal eye movements</p>
            </list-item>
            <list-item>
              <p>Pes cavus</p>
            </list-item>
            <list-item>
              <p>Dysphagia</p>
            </list-item>
            <list-item>
              <p>Autistic traits</p>
            </list-item>
            <list-item>
              <p>Seizures</p>
            </list-item>
            <list-item>
              <p>Dystonia</p>
            </list-item>
            <list-item>
              <p>Cognitive dysfunction</p>
            </list-item>
          </list>
        </sec>
        <sec id="rapid-odp.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of an <italic toggle="yes">ATP1A3</italic>-related neurologic disorder is established when a heterozygous pathogenic variant is detected in <italic toggle="yes">ATP1A3</italic> (encoding the alpha 3 subunit of the Na,K-ATPase) (<xref ref-type="table" rid="rapid-odp.T.summary_of_molecular_genetic">Table 1</xref>).</p>
          <list list-type="bullet">
            <list-item>
              <p>One genetic testing strategy is sequence analysis of <italic toggle="yes">ATP1A3.</italic></p>
            </list-item>
            <list-item>
              <p>An alternative genetic testing strategy is use of a multi-gene panel that includes <italic toggle="yes">ATP1A3</italic> and other genes of interest (see <xref ref-type="sec" rid="rapid-odp.Differential_Diagnosis">Differential Diagnosis</xref>). Note: The genes included and the methods used in multi-gene panels vary by laboratory and over time.</p>
            </list-item>
          </list>
          <table-wrap id="rapid-odp.T.summary_of_molecular_genetic" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in <italic toggle="yes">ATP1A3</italic>-Related Neurologic Disorders</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_rapid-odp.T.summary_of_molecular_genetic_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_rapid-odp.T.summary_of_molecular_genetic_1_1_1_1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_rapid-odp.T.summary_of_molecular_genetic_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_rapid-odp.T.summary_of_molecular_genetic_1_1_1_2">Test Method</th>
                  <th id="hd_h_rapid-odp.T.summary_of_molecular_genetic_1_1_1_3" valign="middle" colspan="3" align="left" scope="colgroup" rowspan="1">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th>
                </tr>
                <tr>
                  <th headers="hd_h_rapid-odp.T.summary_of_molecular_genetic_1_1_1_3" id="hd_h_rapid-odp.T.summary_of_molecular_genetic_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">RDP</th>
                  <th headers="hd_h_rapid-odp.T.summary_of_molecular_genetic_1_1_1_3" id="hd_h_rapid-odp.T.summary_of_molecular_genetic_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">AHC</th>
                  <th headers="hd_h_rapid-odp.T.summary_of_molecular_genetic_1_1_1_3" id="hd_h_rapid-odp.T.summary_of_molecular_genetic_1_1_2_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">CAPOS</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_rapid-odp.T.summary_of_molecular_genetic_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">ATP1A3</italic>
                  </td>
                  <td headers="hd_h_rapid-odp.T.summary_of_molecular_genetic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis of the coding region&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_rapid-odp.T.summary_of_molecular_genetic_1_1_1_3 hd_h_rapid-odp.T.summary_of_molecular_genetic_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">20/53&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_rapid-odp.T.summary_of_molecular_genetic_1_1_1_3 hd_h_rapid-odp.T.summary_of_molecular_genetic_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">~80%</td>
                  <td headers="hd_h_rapid-odp.T.summary_of_molecular_genetic_1_1_1_3 hd_h_rapid-odp.T.summary_of_molecular_genetic_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">4/4</td>
                </tr>
                <tr>
                  <td headers="hd_h_rapid-odp.T.summary_of_molecular_genetic_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_rapid-odp.T.summary_of_molecular_genetic_1_1_1_3 hd_h_rapid-odp.T.summary_of_molecular_genetic_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Not tested&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_rapid-odp.T.summary_of_molecular_genetic_1_1_1_3 hd_h_rapid-odp.T.summary_of_molecular_genetic_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Not tested&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_rapid-odp.T.summary_of_molecular_genetic_1_1_1_3 hd_h_rapid-odp.T.summary_of_molecular_genetic_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">Not tested&#x000a0;<sup>5</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="rapid-odp.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="rapid-odp" object-id="rapid-odp.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="rapid-odp.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="rapid-odp.TF.1.2">
                <label>2. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="rapid-odp.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis identified pathogenic variants in 20 of 53 families referred with "possible" RDP, including 14 cases with <italic toggle="yes">de novo</italic> pathogenic variants [Brashear, personal observation].</p>
              </fn>
              <fn id="rapid-odp.TF.1.4">
                <label>4. </label>
                <p>Testing that identifies exon or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
              <fn id="rapid-odp.TF.1.5">
                <label>5. </label>
                <p>To date there have been no reports of exon or whole-gene deletions/duplications as a cause of <italic toggle="yes">ATP1A3</italic>-related neurologic disorders.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="rapid-odp.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="rapid-odp.Clinical_Description">
          <title>Clinical Description</title>
          <sec id="rapid-odp.RapidOnset_DystoniaParkinsonis">
            <title>Rapid-Onset Dystonia-Parkinsonism (RDP)</title>
            <p>The study of the clinical manifestations of RDP has focused on dystonia/parkinsonism [<xref ref-type="bibr" rid="rapid-odp.REF.dobyns.1993.2596">Dobyns et al 1993</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.brashear.1996.151">Brashear et al 1996</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.brashear.1997.1066">Brashear et al 1997</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.brashear.1998b.335">Brashear et al 1998b</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.kramer.1999.176">Kramer et al 1999</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.pittock.2000.991">Pittock et al 2000</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.linazasoro.2002.608">Linazasoro et al 2002</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.de_carvalho_aguiar.2004.169">de Carvalho Aguiar et al 2004</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.zaremba.2004.1506">Zaremba et al 2004</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.kamphuis.2006.118">Kamphuis et al 2006</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.lee.2007.1808">Lee et al 2007</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.mckeon.2007.1325">McKeon et al 2007</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.kamm.2008.1501">Kamm et al 2008</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.zanottifregonara.2008.148">Zanotti-Fregonara et al 2008</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.anselm.2009.400">Anselm et al 2009</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.blancoarias.2009.2370">Blanco-Arias et al 2009</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.svetel.2010.472">Svetel et al 2010</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.tarsy.2010.2213">Tarsy et al 2010</xref>].</p>
            <p>The clinical presentation of RDP includes the following:</p>
            <list list-type="bullet">
              <list-item>
                <p>Rapid onset of dystonia with parkinsonism (primarily bradykinesia and postural instability) over hours to days to weeks</p>
              </list-item>
              <list-item>
                <p>Appearance of symptoms after triggering events such as running, childbirth, emotional stress, or alcoholic binges</p>
              </list-item>
              <list-item>
                <p>Stability of the phenotype with little improvement after its initial appearance</p>
              </list-item>
              <list-item>
                <p>Low concentration of dopamine metabolites in cerebrospinal fluid in some (not all) patients</p>
              </list-item>
              <list-item>
                <p>Absence of other features including pill-rolling tremor, diurnal fluctuation, and responsiveness to standard medications for parkinsonism</p>
              </list-item>
            </list>
            <p>To date, all known affected individuals have sought medical attention after developing motor symptoms. Of those with motor symptoms and an <italic toggle="yes">ATP1A3</italic> pathogenic variant, most presented with a rostrocaudal topological gradient, rapid onset in less than 30 days, and no response to dopaminergic medications. Many had an identifiable trigger, such as fever, physiologic stress, or alcohol consumption. One individual had antecedent parkinsonism; at least two had fluctuating symptoms before the deficit became permanent.</p>
            <p><bold>Motor findings.</bold> The clinical stages of RDP include: antecedent symptoms, primary onset, and occasional second episodes of worsening.</p>
            <p>Antecedent symptoms have included nonspecific symptoms of dystonia, usually in the hands and arms. Some individuals reported mild limb cramping, most often involving the hands, prior to development of typical RDP following a physiologic stressor. One individual initially had one year of parkinsonism, not dystonia, followed by abrupt onset of oromandibular dystonia with dysarthria.</p>
            <p>Primary onset in individuals with an identified <italic toggle="yes">ATP1A3</italic> pathogenic variant is usually paroxysmal or abrupt over hours to several weeks. In all affected individuals in two large US families, progression stopped at or before one month after onset. Many reported specific triggers consisting of either physical or psychological stress. Alcohol was a trigger in many but not all.</p>
            <p>The bulbar and arm symptoms rarely improve after the primary onset; however, four individuals reported mild improvement in leg symptoms.</p>
            <p>Occasional second episodes of worsening have been reported in a few individuals who experienced episodes of abrupt worsening of symptoms one to nine years after the initial onset. Because only a few affected individuals have been re-examined over an extended time, documentation of second events is incomplete. The second events resemble the primary onset, with worsening of bulbar, arm, and leg symptoms over a similar time course. Except for these second events, little change is reported over many years in those affected individuals for whom such information is available.</p>
            <p><bold>Non-motor features</bold> include mood disorders, substance abuse, and psychosis. Although anxiety is also prevalent among persons with RDP, rates of anxiety did not significantly differ from family-matched controls without RDP [<xref ref-type="bibr" rid="rapid-odp.REF.brashear.2012b.1065">Brashear et al 2012b</xref>]. Cognitive impairment including difficulty with memory and learning, psychomotor speed, attention, and executive functioning has also been reported [<xref ref-type="bibr" rid="rapid-odp.REF.cook.2014.344">Cook et al 2014</xref>]. Seizures have been reported in children and adults [<xref ref-type="bibr" rid="rapid-odp.REF.brashear.1998b.335">Brashear et al 1998b</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.brashear.2012b.1065">Brashear et al 2012b</xref>]<italic toggle="yes">.</italic></p>
          </sec>
          <sec id="rapid-odp.Alternating_Hemiplegia_of_Chil">
            <title>Alternating Hemiplegia of Childhood (AHC)</title>
            <p>Initial descriptions of AHC emphasized the characteristic paroxysmal motor manifestations and noted its similarity to migraine in terms of specific triggers and response to sleep [<xref ref-type="bibr" rid="rapid-odp.REF.verret.1971.675">Verret &#x00026; Steele 1971</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.kr_geloh.1980.784">Kr&#x000e4;geloh &#x00026; Aicardi 1980</xref>].</p>
            <p>AHC is a complex neurodevelopmental syndrome which most frequently manifests in infancy or early childhood with paroxysmal neurologic symptoms that can last for minutes to hours to even days and sometimes weeks, with remission of symptoms only during sleep and the immediate period post awakening.</p>
            <p>While neonates and young infants often present with seizure-like episodes, eye movement abnormalities, and autonomic manifestations, they can also present with episodes of flaccid quadriparesis. Paroxysmal episodic neurologic dysfunction is the predominant feature early in the disease course; as affected children age, interictal persistent neurologic dysfunction (including oculomotor apraxia, ataxia, dystonia, parkinsonism, and cognitive and behavioral dysfunction) increases.</p>
            <p>More than 50% of children with AHC manifest clinical seizure activity by early childhood. Status epilepticus and status dystonicus can be life-threatening complications in some. For reviews, see <xref ref-type="bibr" rid="rapid-odp.REF.sweney.2009.e534">Sweney et al [2009]</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.panagiotakaki.2010.3598">Panagiotakaki et al [2010]</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.kansagra.2013.821">Kansagra et al [2013]</xref>, and <xref ref-type="bibr" rid="rapid-odp.REF.heinzen.2014.503">Heinzen et al [2014]</xref>.</p>
            <p>Paroxysmal neurologic symptoms include the following:</p>
            <list list-type="bullet">
              <list-item>
                <p>Ocular movement abnormalities (monocular or binocular nystagmus, intermittent eso- or exotropia, skew deviation, ocular bobbing, ocular flutter)</p>
              </list-item>
              <list-item>
                <p>Hemiparesis or hemiplegia which can alternate from side to side</p>
              </list-item>
              <list-item>
                <p>Quadriparesis or quadriplegia</p>
              </list-item>
              <list-item>
                <p>Unilateral tonic or dystonic posturing of one or more limbs, or generalized dystonic posturing</p>
              </list-item>
              <list-item>
                <p>Autonomic manifestations including unilateral or bilateral pupillary dilatation, flushing, pallor affecting one limb or hemibody</p>
              </list-item>
              <list-item>
                <p>More complex dyskinesias</p>
              </list-item>
              <list-item>
                <p>Headache</p>
              </list-item>
              <list-item>
                <p>Epilepsy (focal, partial, or generalized tonic-clonic)</p>
              </list-item>
              <list-item>
                <p>Status epilepticus or status dystonicus</p>
              </list-item>
            </list>
            <p>Persistent, interictal neurologic symptoms that become increasingly evident with age include:</p>
            <list list-type="bullet">
              <list-item>
                <p>Ataxia</p>
              </list-item>
              <list-item>
                <p>Oculomotor apraxia</p>
              </list-item>
              <list-item>
                <p>Strabismus</p>
              </list-item>
              <list-item>
                <p>Hypotonia or rigidity</p>
              </list-item>
              <list-item>
                <p>Choreoathetosis</p>
              </list-item>
              <list-item>
                <p>Impaired articulation or bulbar function</p>
              </list-item>
              <list-item>
                <p>Generalized or focal dystonia</p>
              </list-item>
              <list-item>
                <p>Areflexia or hyperreflexia</p>
              </list-item>
            </list>
            <p>Non-motor interictal neurologic symptoms include:</p>
            <list list-type="bullet">
              <list-item>
                <p>Speech and language delay</p>
              </list-item>
              <list-item>
                <p>Behavioral outbursts, impulsivity</p>
              </list-item>
              <list-item>
                <p>Aggression</p>
              </list-item>
              <list-item>
                <p>Cognitive delay or intellectual disabilities</p>
              </list-item>
              <list-item>
                <p>Mood disorders</p>
              </list-item>
            </list>
          </sec>
          <sec id="rapid-odp.CAPOS_Syndrome">
            <title>CAPOS Syndrome</title>
            <p>CAPOS syndrome has been described to date in three families and one individual with a <italic toggle="yes">de novo</italic> pathogenic variant. It presents in infancy or childhood with cerebellar ataxia after a fever, and eventually a characteristic set of symptoms. Symptoms during the acute febrile encephalopathy have included hypotonia, flaccidity, nystagmus, strabismus, dysarthria, anarthria, lethargy, loss of consciousness, and even coma. There is usually considerable recovery within days to weeks, but persistence of some ataxia and other symptoms is typical. Other features include areflexia, pes cavus, progressive sensorineural hearing loss, and optic atrophy [<xref ref-type="bibr" rid="rapid-odp.REF.nicolaides.1996.419">Nicolaides et al 1996</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.demos.2014.15">Demos et al 2014</xref>].</p>
            <p>Features common to all known patients with CAPOS include cerebellar ataxia, areflexia, progressive optic atrophy, and sensorineural hearing loss. Features seen in one or more affected individuals include abnormal eye movements (n=5), pes cavus (n=3), dysphagia (n=2), autistic traits (n=2), brief seizures during acute illness (n=1), dystonia (n=1), and cognitive dysfunction (n=1) [<xref ref-type="bibr" rid="rapid-odp.REF.demos.2014.15">Demos et al 2014</xref>].</p>
            <p>Onset and progression of optic atrophy and sensorineural hearing loss are not well characterized but appear to progress over time. Only three of the affected individuals examined to date were older than age 22 years. Motor impairment ranged from mild difficulties with balance to severely ataxic gait.</p>
          </sec>
          <sec id="rapid-odp.CNS_Studies_in_the_ATP1A3Relat">
            <title>CNS Studies in the <italic toggle="yes">ATP1A3</italic>-Related Neurologic Disorders</title>
            <p>
              <bold>Brain imaging (MRI, CT)</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p><bold>RDP.</bold> Normal</p>
              </list-item>
              <list-item>
                <p><bold>AHC.</bold> Early in the course of the disease, typically normal. Later in the disease course, more subtle abnormalities (including diffuse cerebral atrophy and/or isolated cerebellar atrophy, or mesial temporal sclerosis) described in a small number of patients [<xref ref-type="bibr" rid="rapid-odp.REF.sweney.2009.e534">Sweney et al 2009</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.sasaki.2014a.153">Sasaki et al 2014a</xref>].</p>
              </list-item>
              <list-item>
                <p><bold>CAPOS syndrome.</bold> Normal [<xref ref-type="bibr" rid="rapid-odp.REF.nicolaides.1996.419">Nicolaides et al 1996</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.demos.2014.15">Demos et al 2014</xref>]</p>
              </list-item>
            </list>
            <p>
              <bold>Brain function studies</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>
                  <bold>RDP</bold>
                </p>
                <list list-type="bullet">
                  <list-item>
                    <p>Position emission tomography(PET) studies using the dopamine transporter imaging agent [<sup>11</sup>C]&#x003b2;-CFT did not show a decrease in dopamine reuptake sites [<xref ref-type="bibr" rid="rapid-odp.REF.brashear.1999.132">Brashear et al 1999</xref>].</p>
                  </list-item>
                  <list-item>
                    <p>Striatal [123I]-FP-CIT uptake in one individual with RDP with a previously undescribed <italic toggle="yes">ATP1A3</italic> pathogenic variant was just within the normal range. [99mTc]-HMPAO scan was also normal [<xref ref-type="bibr" rid="rapid-odp.REF.zanottifregonara.2008.148">Zanotti-Fregonara et al 2008</xref>].</p>
                  </list-item>
                  <list-item>
                    <p>Transcranial sonography in an individual with a previously undescribed <italic toggle="yes">ATP1A3</italic> pathogenic variant revealed bilateral hyperechogenicity of the substantia nigra, the significance of which is unknown [<xref ref-type="bibr" rid="rapid-odp.REF.svetel.2010.472">Svetel et al 2010</xref>].</p>
                  </list-item>
                </list>
              </list-item>
              <list-item>
                <p><bold>AHC.</bold> SPECT scans performed during prolonged episodes of hemiplegia typically demonstrate hypometabolism on the hemisphere opposite the side of paralysis, in contrast to the hyperperfusion seen associated with epileptic activity [<xref ref-type="bibr" rid="rapid-odp.REF.dangond.1997.35">Dangond et al 1997</xref>].</p>
              </list-item>
            </list>
            <p>
              <bold>Cerebral blood flow</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p><bold>RDP.</bold> Cerebral blood flow was similar in persons with RDP when compared with age-matched controls [<xref ref-type="bibr" rid="rapid-odp.REF.brashear.1999.132">Brashear et al 1999</xref>].</p>
              </list-item>
              <list-item>
                <p><bold>AHC.</bold> Magnetic resonance angiography (MRA) studies examining cerebral blood flow in the setting of acute hemiplegic episodes have failed to demonstrate significant vascular flow abnormalities [<xref ref-type="bibr" rid="rapid-odp.REF.sweney.2009.e534">Sweney et al 2009</xref>].</p>
              </list-item>
            </list>
            <p>
              <bold>CSF neurotransmitter studies</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p><bold>RDP.</bold> Cerebrospinal fluid (CSF) concentration of the dopamine metabolite homovanillic acid (HVA) which was low in one symptomatic individual with an <italic toggle="yes">ATP1A3</italic> pathogenic variant increased after L-dopa treatment, but not in another individual with the same pathogenic variant, and did not correlate with clinical improvement. In addition, an asymptomatic individual who was heterozygous for an <italic toggle="yes">ATP1A3</italic> pathogenic variant also had low CSF HVA levels. Thus, based on data currently available, CSF HVA levels are not diagnostic [<xref ref-type="bibr" rid="rapid-odp.REF.brashear.1998a.521">Brashear et al 1998a</xref>].</p>
              </list-item>
              <list-item>
                <p><bold>AHC.</bold> CSF studies including neurotransmitter metabolite studies are usually normal.</p>
              </list-item>
              <list-item>
                <p><bold>CAPOS syndrome</bold>. CSF concentration of neurotransmitter metabolites has not been reported.</p>
              </list-item>
            </list>
          </sec>
        </sec>
        <sec id="rapid-odp.Pathophysiology">
          <title>Pathophysiology</title>
          <p>Neuropathology specimens from persons with RDP show changes in neuronal pathways, suggesting involvement of cerebral and cerebellar connections necessary for motor control [<xref ref-type="bibr" rid="rapid-odp.REF.oblak.2014.81">Oblak et al 2014</xref>].</p>
        </sec>
        <sec id="rapid-odp.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Genotype-phenotype correlations for the three identified phenotypes (RDP, AHC, and CAPOS syndrome) are complex.</p>
          <list list-type="bullet">
            <list-item>
              <p>Virtually all pathogenic variants that have been studied experimentally make one-residue changes to the protein and reduce activity, Na<sup>+</sup> affinity, or the stability of the protein. There is a tendency for high inhibition with stable protein to manifest as AHC, while pathogenic variants associated with RDP retain some activity or result in poor protein expression [reviewed in <xref ref-type="bibr" rid="rapid-odp.REF.heinzen.2014.503">Heinzen et al 2014</xref>].</p>
            </list-item>
            <list-item>
              <p>The pathogenic variant c.2767G&#x0003e;A (encoding p.Asp923Asn) is the only variant reported in both RDP and AHC [<xref ref-type="bibr" rid="rapid-odp.REF.roubergue.2013.1457">Roubergue et al 2013</xref>].</p>
            </list-item>
            <list-item>
              <p>One study found that patients with AHC and the pathogenic variant p.Glu815Lys may have earlier onset of symptoms and greater motor and cognitive impairment, and more often experience status epilepticus and respiratory paralysis [<xref ref-type="bibr" rid="rapid-odp.REF.sasaki.2014b.482">Sasaki et al 2014b</xref>].</p>
            </list-item>
            <list-item>
              <p>The same heterozygous <italic toggle="yes">ATP1A3</italic> pathogenic missense variant c.2452G&#x0003e;A (p.Glu818Lys) was reported in all individuals with CAPOS syndrome (3 unrelated families and 1 individual with a <italic toggle="yes">de novo</italic> pathogenic variant) [<xref ref-type="bibr" rid="rapid-odp.REF.rosewich.2014c.861">Rosewich et al 2014c</xref>].</p>
            </list-item>
            <list-item>
              <p>Intermediate phenotypes have also been reported [<xref ref-type="bibr" rid="rapid-odp.REF.anselm.2009.400">Anselm et al 2009</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.brashear.2012b.1065">Brashear et al 2012b</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.rosewich.2014a.133">Rosewich et al 2014a</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.sasaki.2014a.153">Sasaki et al 2014a</xref>], consistent with the spectrum of phenotypes observed to date.</p>
            </list-item>
          </list>
          <p>Genotype-phenotype correlations with RDP were reported by <xref ref-type="bibr" rid="rapid-odp.REF.brashear.2007.828">Brashear et al [2007]</xref> based on <italic toggle="yes">ATP1A3</italic> sequence analysis in 49 persons from 21 families referred with "possible" RDP; see <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="rapid-odp-Table2.pdf" content-type="local-data">Table 2</inline-supplementary-material> (pdf). Pathogenic variants were identified in 36 persons from ten families, including three that were <italic toggle="yes">de novo</italic> and one in a single individual whose family members were not tested. No pathogenic variants were found in 13 persons from 11 families. Several additional individuals with similar clinical features are also included in <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="rapid-odp-Table2.pdf" content-type="local-data">Table 2</inline-supplementary-material>.</p>
          <p>Comparison of onset, topological gradient (i.e., rostrocaudal or vice versa), and presence of bulbar symptoms, tremor, and pain in individuals with and without pathogenic variants in <italic toggle="yes">ATP1A3</italic> revealed the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>All 36 individuals with rapid-onset (p=0.002), rostrocaudal topological gradient (p&#x0003c;0.001) and bulbar symptoms (p&#x0003c;0.001) had a pathogenic variant. Note: These three findings also characterized one of 13 persons who did not have a pathogenic variant. Unlike the 36 individuals in whom a pathogenic variant was found, this individual responded to anticholinergic therapy, making it likely that the findings in this case represent a phenocopy.</p>
            </list-item>
            <list-item>
              <p>None of the 36 individuals with a pathogenic variant reported tremor (p=0.003) or severe pain (p=0.051).</p>
            </list-item>
            <list-item>
              <p>Four of the 13 individuals who did not have a pathogenic variant reported tremor at onset; two of 11 reported pain (data available on 9 only). The presence of pain and tremor in an affected individual appears to signal decreased likelihood of a pathogenic variant in <italic toggle="yes">ATP1A3</italic>. Note: It is not clear if this is an absolute distinction, as tremor was reported later in life in a small number of affected individuals with pathogenic variants from two families.</p>
            </list-item>
          </list>
        </sec>
        <sec id="rapid-odp.Penetrance">
          <title>Penetrance</title>
          <p><bold>RDP.</bold> Penetrance is incomplete. The small number of families with RDP studied to date limits the estimate of penetrance; however, several members of the larger reported families have had a heterozygous <italic toggle="yes">ATP1A3</italic> pathogenic variant but were asymptomatic [<xref ref-type="bibr" rid="rapid-odp.REF.kramer.1999.176">Kramer et al 1999</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.de_carvalho_aguiar.2004.169">de Carvalho Aguiar et al 2004</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.brashear.2007.828">Brashear et al 2007</xref>].</p>
          <p><bold>AHC.</bold> Penetrance is even more uncertain, as most <italic toggle="yes">ATP1A3</italic> pathogenic variants reported to date have occurred <italic toggle="yes">de novo</italic>.</p>
          <p><bold>CAPOS syndrome.</bold> There is no evidence of incomplete penetrance in the three families reported to date [<xref ref-type="bibr" rid="rapid-odp.REF.demos.2014.15">Demos et al 2014</xref>].</p>
        </sec>
        <sec id="rapid-odp.Nomenclature">
          <title>Nomenclature</title>
          <p>The nomenclature of all three disorders, based on early clinical categorization, is useful for highlighting symptoms that provide a starting point for diagnosis.</p>
          <p><bold>Rapid-onset dystonia-parkinsonism (RDP)</bold> was first recognized and named by <xref ref-type="bibr" rid="rapid-odp.REF.dobyns.1993.2596">Dobyns et al [1993]</xref> in a 15-year-old girl with an abrupt onset of dystonia with severe bulbar symptoms and some signs of parkinsonism (postural instability with bradykinesia). Cerebrospinal fluid levels of dopamine metabolites were low; thus, the term RDP was used to describe what later came to be known as DYT12 caused by mutation of <italic toggle="yes">ATP1A3</italic> (see <related-object link-type="booklink" source-id="gene" document-id="dystonia-ov" document-type="chapter">Dystonia Overview</related-object>). Because classic signs of Parkinson disease, such as tremor, are unusual in individuals with RDP, the term parkinsonism in the designation RDP represents a subset of parkinsonian symptoms, and the disorder is classified as dystonia-plus (combined dystonia).</p>
          <p><bold>Alternating hemiplegia of childhood (AHC)</bold> was named for its most striking and diagnostic motor symptom; however, the range of manifestations show it to be a CNS disorder affecting function broadly in various brain circuits, and the disease evolves with age.</p>
          <p><bold><italic toggle="yes">C</italic>erebellar ataxia, <italic toggle="yes">a</italic>reflexia, <italic toggle="yes">p</italic>es cavus, <italic toggle="yes">o</italic>ptic atrophy, and <italic toggle="yes">s</italic>ensorineural hearing loss (CAPOS) syndrome</bold> was named for a unique cluster of symptoms. It is now recognized to share characteristics with RDP and AHC; however, the fact that to date the same <italic toggle="yes">ATP1A3</italic> pathogenic variant has been observed in the three unrelated families and one individual with a <italic toggle="yes">de novo</italic> pathogenic variant supports the continued use of the term.</p>
        </sec>
        <sec id="rapid-odp.Prevalence">
          <title>Prevalence</title>
          <p><bold>RDP.</bold> The prevalence is not known. RDP has been described in individuals and families from the US, Europe, and Korea, and in an individual of African-Caribbean descent [<xref ref-type="bibr" rid="rapid-odp.REF.webb.1999.171">Webb et al 1999</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.de_carvalho_aguiar.2004.169">de Carvalho Aguiar et al 2004</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.zaremba.2004.1506">Zaremba et al 2004</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.brashear.2007.828">Brashear et al 2007</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.lee.2007.1808">Lee et al 2007</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.kamm.2008.1501">Kamm et al 2008</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.zanottifregonara.2008.148">Zanotti-Fregonara et al 2008</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.anselm.2009.400">Anselm et al 2009</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.blancoarias.2009.2370">Blanco-Arias et al 2009</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.svetel.2010.472">Svetel et al 2010</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.tarsy.2010.2213">Tarsy et al 2010</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.pekmezovic.2009.161">Pekmezovic et al 2009</xref>].</p>
          <p><bold>AHC.</bold> The prevalence of the classic AHC phenotype has been estimated at 1 in 1,000,000.</p>
          <p><bold>CAPOS syndrome.</bold> The prevalence of CAPOS syndrome is not known</p>
        </sec>
      </sec>
      <sec id="rapid-odp.Genetically_Related_Allelic_Di">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are currently reported to be associated with mutation of <italic toggle="yes">ATP1A3.</italic></p>
      </sec>
      <sec id="rapid-odp.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold>Possible alternative loci.</bold> It is unclear whether mutation of genes at other loci is also causative of the classically described rapid-onset dystonia-parkinsonism (RDP) or alternating hemiplegia of childhood (AHC) phenotypes, but it is highly probable.</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>RDP.</bold> Although no other genes or loci are known to be associated with RDP, not all individuals with a phenotype consistent with RDP have an <italic toggle="yes">ATP1A3</italic> pathogenic variant; therefore, it is possible that mutation of another gene or genes causes RDP. For example, in a German family in which eight members had RDP, none had a pathogenic variant in <italic toggle="yes">ATP1A3</italic> and none showed linkage to the <italic toggle="yes">ATP1A3</italic> locus on chromosome 19, suggesting the presence of at least one additional locus for RDP [<xref ref-type="bibr" rid="rapid-odp.REF.kabakci.2005.860">Kabakci et al 2005</xref>]. Of note, five of the eight affected members had concurrent renal disease, which has not been seen in individuals with an <italic toggle="yes">ATP1A3</italic> pathogenic variant.</p>
          </list-item>
          <list-item>
            <p><bold>AHC.</bold> Locus heterogeneity in AHC is strongly suggested by the identification of infants and children with a phenotype meeting the classic clinical criteria for AHC but within whom no apparent pathogenic variant involving <italic toggle="yes">ATP1A3</italic> or the ATP1A3 locus have been identified.</p>
          </list-item>
        </list>
        <p>Locus heterogeneity is unknown for <italic toggle="yes">c</italic>erebellar ataxia, <italic toggle="yes">a</italic>reflexia, <italic toggle="yes">p</italic>es cavus, <italic toggle="yes">o</italic>ptic atrophy, and <italic toggle="yes">s</italic>ensorineural hearing loss (CAPOS) syndrome.</p>
        <p>Three neurologic diseases associated with pathogenic variants in the homologous gene <italic toggle="yes">ATP1A2</italic> have some overlapping clinical manifestations: infantile seizures, <related-object link-type="booklink" source-id="gene" document-id="fhm" document-type="chapter">familial hemiplegic migraine</related-object> (FHM2), and familial common migraine [<xref ref-type="bibr" rid="rapid-odp.REF.de_fusco.2003.192">De Fusco et al 2003</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.vanmolkot.2003.360">Vanmolkot et al 2003</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.bassi.2004.621">Bassi et al 2004</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.kaunisto.2004.141">Kaunisto et al 2004</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.swoboda.2004.884">Swoboda et al 2004</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.ambrosini.2005.1826">Ambrosini et al 2005</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.todt.2005.315">Todt et al 2005</xref>]. Despite the related genes and manifestations of hemiplegia and seizure, <italic toggle="yes">ATP1A2</italic> is expressed mainly in astrocytes instead of neurons [<xref ref-type="bibr" rid="rapid-odp.REF.mcgrail.1991.381">McGrail et al 1991</xref>], and the underlying pathophysiology is likely to be different from that of <italic toggle="yes">ATP1A3</italic>-related diseases.</p>
        <p><bold>RDP.</bold> The presence of tremor at onset of symptoms, a reversed rostrocaudal topological gradient, and significant limb pain exclude the diagnosis of rapid-onset dystonia-parkinsonism (RDP) [<xref ref-type="bibr" rid="rapid-odp.REF.brashear.2007.828">Brashear et al 2007</xref>].</p>
        <p>The physician needs to exclude more common and treatable forms of dystonia-parkinsonism (see <related-object link-type="booklink" source-id="gene" document-id="dystonia-ov" document-type="chapter">Dystonia Overview</related-object> and <related-object link-type="booklink" source-id="gene" document-id="parkinson-overview" document-type="chapter">Parkinson Disease Overview</related-object>). Testing should include brain MRI, a trial of L-dopa, <italic toggle="yes">TOR1A</italic> (<related-object link-type="booklink" source-id="gene" document-id="dystonia" document-type="chapter"><italic toggle="yes">DYT1</italic></related-object>) testing, and evaluation for <related-object link-type="booklink" source-id="gene" document-id="wilson" document-type="chapter">Wilson disease</related-object>. In RDP, the MRI is normal and the response to L-dopa is minimal or none.</p>
        <p>The differential diagnosis of RDP includes the following:</p>
        <list list-type="bullet">
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="drd" document-type="chapter"><bold>Dopa-responsive dystonia</bold></related-object>
<bold>(DRD)</bold> differs from RDP in the response to L-dopa, which is minimal in those with RDP [<xref ref-type="bibr" rid="rapid-odp.REF.bressman.2002.1780">Bressman et al 2002</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.kabakci.2005.860">Kabakci et al 2005</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.geyer.2006.780">Geyer &#x00026; Bressman 2006</xref>]. Furthermore, DRD typically presents in the leg and, in some reports, has been confused with cerebral palsy [<xref ref-type="bibr" rid="rapid-odp.REF.nygaard.1994.236">Nygaard et al 1994</xref>].</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="dystonia" document-type="chapter"><bold>DYT1 dystonia</bold></related-object>, unlike RDP, has a more caudal to rostral gradient. Onset of DYT1 dystonia in older individuals is rare, whereas RDP may present abruptly after age 30 years.</p>
          </list-item>
          <list-item>
            <p><bold>Young-onset parkinsonism.</bold> Individuals with young-onset parkinsonism may have limb dystonia as an early manifestation; however, unlike persons with RDP, they should have a significant and sustained response to L-dopa. Other recently described genetic forms of Parkinson disease including <related-object link-type="booklink" source-id="gene" document-id="pink1-pd" document-type="chapter"><italic toggle="yes">PINK1</italic> type of young-onset Parkinson disease</related-object> and <related-object link-type="booklink" source-id="gene" document-id="jpd" document-type="chapter">parkin type of juvenile Parkinson disease</related-object> should be considered.</p>
          </list-item>
          <list-item>
            <p><bold>Other.</bold> A kindred of eight individuals with RDP who have neither a pathogenic variant in <italic toggle="yes">ATP1A3</italic> nor linkage to chromosome 19q in the DYT12 region is an apparent phenocopy [<xref ref-type="bibr" rid="rapid-odp.REF.kabakci.2005.860">Kabakci et al 2005</xref>]. The proband presented at age six years with overnight onset of dysphonia, dysphagia, orofacial dystonia, and dystonia of all four limbs, findings which meet the diagnostic criteria for RDP. However, five of the eight affected individuals had renal disease consisting of renal hypoplasia, renal cysts, and/or end-stage renal disease, which has not been observed in individuals with RDP and <italic toggle="yes">ATP1A3</italic> pathogenic variants.</p>
          </list-item>
        </list>
        <p><bold>AHC.</bold> Given the early onset and protean neurologic symptoms in affected infants and young children, the differential diagnosis of AHC is unavoidably broad.</p>
        <p>It is particularly important early in the diagnostic evaluation of an individual suspected of having AHC to exclude metabolic disorders or vascular syndromes that could benefit from specific therapeutic approaches, such as moyamoya disease, mitochondrial disorders including pyruvate dehydrogenase deficiency (in which spells are typically accompanied by lactic acidosis), and <related-object link-type="booklink" source-id="gene" document-id="glut1" document-type="chapter">GLUT1 deficiency</related-object>, which responds to a ketogenic diet.</p>
        <p>The often prolonged episodes of hemiparesis, dystonia, or quadriplegia observed early in the course of AHC are typically not associated with epileptiform activity on EEG, which can help to distinguish AHC from infantile-onset epileptic encephalopathy syndromes.</p>
        <p>The paroxysmal nature of symptoms in AHC can mimic inborn errors of neurotransmitter biosynthesis and metabolism such as aromatic L-amino acid decarboxylase (AADC) deficiency and <related-object link-type="booklink" source-id="gene" document-id="thdrd" document-type="chapter">tyrosine hydroxylase (TH) deficiency</related-object>. Studies of CSF neurotransmitters are necessary to exclude this group of disorders, and ideally should be performed as part of the diagnostic workup early in the clinical course (and prior to <italic toggle="yes">ATP1A3</italic> molecular genetic testing), since alternative treatments for these disorders (e.g., neurotransmitter precursors and pyridoxine or dopamine receptor agonist therapy) are available.</p>
        <p>Specific disorders and alternative genetic etiologies to consider include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Pyruvate dehydrogenase deficiency, <related-object link-type="booklink" source-id="gene" document-id="melas" document-type="chapter">MELAS</related-object>, and other <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">mitochondrial disorders</related-object></p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="glut1" document-type="chapter">Glut1 deficiency syndromes</related-object> [<xref ref-type="bibr" rid="rapid-odp.REF.rotstein.2009.2042">Rotstein et al 2009</xref>]</p>
          </list-item>
          <list-item>
            <p>Inborn errors of neurotransmitter biosynthesis and metabolism [<xref ref-type="bibr" rid="rapid-odp.REF.sweney.2009.e534">Sweney et al 2009</xref>], especially disorders with deficient dopamine biosynthesis including AADC, TH, DHPR or PPTS deficiency</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="fhm" document-type="chapter"><italic toggle="yes">ATP1A2</italic>-related disorders</related-object> [<xref ref-type="bibr" rid="rapid-odp.REF.swoboda.2004.884">Swoboda et al 2004</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.jen.2007.523">Jen et al 2007</xref>]</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">CACNA1A</italic>-related disorders : <related-object link-type="booklink" source-id="gene" document-id="fhm" document-type="chapter">familial hemiplegic migraine 1</related-object>, <related-object link-type="booklink" source-id="gene" document-id="ea2" document-type="chapter">episodic ataxia 2</related-object>, and <related-object link-type="booklink" source-id="gene" document-id="sca6" document-type="chapter">spinocerebellar ataxia type 6</related-object> (SCA6)</p>
          </list-item>
          <list-item>
            <p>SLC1A3 glutamate transporter-related disorders [<xref ref-type="bibr" rid="rapid-odp.REF.jen.2005.529">Jen et al 2005</xref>] (episodic ataxia 6)</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">SCN1A</italic>-related disorders [<xref ref-type="bibr" rid="rapid-odp.REF.kim.2013.440">Kim et al 2013</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.weller.2014.1062">Weller et al 2014</xref>] (<related-object link-type="booklink" source-id="gene" document-id="gefs" document-type="chapter"><italic toggle="yes">SCN1A-</italic>related seizure disorders</related-object> and <related-object link-type="booklink" source-id="gene" document-id="fhm" document-type="chapter">familial hemiplegic migraine 3</related-object>)</p>
          </list-item>
        </list>
        <p><bold>CAPOS syndrome</bold> is unique, and each of its major symptoms has multiple etiologies as separate conditions. The combination of features, particularly sensorineural hearing loss in association with pes cavus deformity, elicits a rather broad differential diagnosis including mitochondrial and peroxisomal disorders.</p>
      </sec>
      <sec id="rapid-odp.Management">
        <title>Management</title>
        <sec id="rapid-odp.Evaluations_Following_Initial">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with a known <italic toggle="yes">ATP1A3</italic>-related neurologic disorder, the following evaluations are recommended:</p>
          <p>
            <bold>Rapid-onset dystonia-parkinsonism (RDP)</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Brain imaging to exclude stroke</p>
            </list-item>
            <list-item>
              <p>EEG to evaluate possibility of seizures</p>
            </list-item>
            <list-item>
              <p>Neuropsychological testing to evaluate cognitive or memory problems</p>
              <p>Note: Questionnaires to prompt treating clinicians to elicit history and observations relevant to disease symptoms and management may be obtained from organizations included in <xref ref-type="sec" rid="rapid-odp.Resources">Resources</xref>.</p>
            </list-item>
          </list>
          <p>
            <bold>Alternating hemiplegia of childhood (AHC)</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Brain imaging to exclude stroke</p>
            </list-item>
            <list-item>
              <p>EEG to evaluate possibility of seizures</p>
              <p>Note: Questionnaires to prompt treating clinicians to elicit history and observations relevant to disease symptoms and management may be obtained from organizations included in <xref ref-type="sec" rid="rapid-odp.Resources">Resources</xref>.</p>
            </list-item>
          </list>
          <p>
            <bold><italic toggle="yes">C</italic>erebellar ataxia, <italic toggle="yes">a</italic>reflexia, <italic toggle="yes">p</italic>es cavus, <italic toggle="yes">o</italic>ptic atrophy, and <italic toggle="yes">s</italic>ensorineural hearing loss (CAPOS) syndrome</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Brain imaging to evaluate the cerebellum</p>
            </list-item>
            <list-item>
              <p>EMG for areflexia and assessment for pes cavus to evaluate for peripheral neuropathy</p>
            </list-item>
            <list-item>
              <p>Ophthalmology consult and OCT (optical coherence tomography) for evaluation of optic atrophy</p>
            </list-item>
            <list-item>
              <p>Audiogram and hearing specialist consultation to evaluate sensorineural hearing loss</p>
            </list-item>
          </list>
        </sec>
        <sec id="rapid-odp.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>
            <bold>For all phenotypes</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Critical care: standard management of manifestations such as seizure or apnea</p>
              <p>Note: A seizure care plan, with provision of rescue therapy for prolonged seizures if indicated, is strongly recommended for those in whom epilepsy has been confirmed by either electrodiagnostic testing or highly suggestive clinical features.</p>
            </list-item>
            <list-item>
              <p>Occupational therapy to maximize motor function</p>
            </list-item>
            <list-item>
              <p>Speech therapy for dysarthria</p>
            </list-item>
          </list>
          <p><bold>RDP.</bold> In a few patients with RDP decreased spasms have been noted with high-dose benzodiazepines. Dosing should be judged by the physician on an individual basis.</p>
          <p>Standard therapies for the following are appropriate:</p>
          <list list-type="bullet">
            <list-item>
              <p>Seizures</p>
            </list-item>
            <list-item>
              <p>Dysphagia</p>
            </list-item>
            <list-item>
              <p>Psychotherapy for mood disorder (such as depression and anxiety), substance abuse, and/or psychosis</p>
            </list-item>
          </list>
          <p>Two individuals treated with deep brain stimulation [<xref ref-type="bibr" rid="rapid-odp.REF.kamm.2008.1501">Kamm et al 2008</xref>] did not show marked improvement [A Brashear, personal communication].</p>
          <p><bold>AHC.</bold> Medical treatment generally involves the following [<xref ref-type="bibr" rid="rapid-odp.REF.neville.2007.777">Neville &#x00026; Ninan 2007</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Episode prophylaxis</bold> (avoiding <xref ref-type="sec" rid="rapid-odp.AgentsCircumstances_to_Avoid">triggers</xref>; reducing the frequency and/or severity of recurrent paroxysmal episodes by sleep &#x02013; either natural or induced with daily prophylactic medications):</p>
              <list list-type="bullet">
                <list-item>
                  <p>Prophylactic medications</p>
                  <list list-type="bullet">
                    <list-item>
                      <p>Flunarizine. Symptomatic benefit in reducing the frequency and/or severity of the recurrent paroxysmal episodes of neurologic dysfunction has been reported with flunarizine [<xref ref-type="bibr" rid="rapid-odp.REF.silver.1993.36">Silver &#x00026; Andermann 1993</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.sasaki.2001.303">Sasaki 2001</xref>]. Flunarizine has been examined in a few small series of patients, and is reported to decrease the frequency and/or severity of the episodic dystonic and/or plegic episodes. In spite of the lack of well-designed placebo-controlled trials, flunarizine has remained the most commonly prescribed therapy for prophylaxis of episodic neurologic dysfunction in AHC for more than two decades. Note that abrupt withdrawal of the medication has been associated with deterioration in clinical status [<xref ref-type="bibr" rid="rapid-odp.REF.sweney.2009.e534">Sweney et al 2009</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.sasaki.2014a.153">Sasaki et al 2014a</xref>].</p>
                    </list-item>
                    <list-item>
                      <p>Topiramate is another commonly prescribed agent for prophylaxis [<xref ref-type="bibr" rid="rapid-odp.REF.jiang.2006.229">Jiang et al 2006</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.chi.2012.506">Chi et al 2012</xref>].</p>
                    </list-item>
                  </list>
                </list-item>
                <list-item>
                  <p><bold>Sleep.</bold> Placing the affected individual in a quiet, dark room or putting a child down for a nap can help alleviate severe episodes and/or promote an earlier recovery.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Acute attack management</bold> with use of various rescue medications including:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Benzodiazepines, which are commonly used and reported to be of some benefit in increasingly the tolerability of episodes, especially for severe or prolonged dystonic episodes</p>
                </list-item>
                <list-item>
                  <p>Chloral hydrate</p>
                </list-item>
                <list-item>
                  <p>Other sleep inducers</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>A low threshold for suspicion of seizure activity is critical, particularly in the setting of either recurrent brief or more prolonged tonic or dystonic episodes associated with alterations in consciousness or apparent awareness of their environment. Epilepsy management utilizes existing anticonvulsants.</p>
          <p>Recently, two separate reports described patients with AHC who responded to a ketogenic diet [<xref ref-type="bibr" rid="rapid-odp.REF.ulatecampos.2014.377">Ulate-Campos et al 2014</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.roubergue.2015.7">Roubergue et al 2015</xref>].</p>
          <p><bold>CAPOS syndrome.</bold> Symptomatic treatment includes hearing and visual aids.</p>
        </sec>
        <sec id="rapid-odp.Prevention_of_Secondary_Compli">
          <title>Prevention of Secondary Complications</title>
          <p>When dystonia is present, physical therapy to prevent contractures in the hands and feet is appropriate.</p>
        </sec>
        <sec id="rapid-odp.Surveillance">
          <title>Surveillance</title>
          <p>Patients with RDP need to be monitored for evidence of:</p>
          <list list-type="bullet">
            <list-item>
              <p>Dysphagia, which (rarely) requires use of a feeding tube</p>
            </list-item>
            <list-item>
              <p>Psychiatric symptoms</p>
            </list-item>
            <list-item>
              <p>Seizures, which are reported in some individuals following acute onset of RDP</p>
            </list-item>
          </list>
          <p>Patients with AHC need to be monitored for evidence of seizures which occur over time in a large proportion of affected individuals.</p>
          <p>Patients with CAPOS syndrome need to be monitored for evidence of swallow dysfunction in order to reduce the risk of aspiration</p>
        </sec>
        <sec id="rapid-odp.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>At-risk family members and asymptomatic individuals with an <italic toggle="yes">ATP1A3</italic> pathogenic variant are cautioned to avoid alcohol or excessive exercise.</p>
          <p>Infections and fever also are common triggers, and although practical prevention strategies are lacking, unnecessary exposure should be avoided. There is no known reason to avoid vaccinations.</p>
          <p><bold>RDP.</bold> Triggers associated with the abrupt onset of RDP that should be avoided include (but are not limited to) the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Alcohol</p>
            </list-item>
            <list-item>
              <p>Fever</p>
            </list-item>
            <list-item>
              <p>Psychological stress</p>
            </list-item>
            <list-item>
              <p>Excessive exercise (such as running track)</p>
            </list-item>
          </list>
          <p><bold>AHC.</bold> Triggers associated with inducing paroxysmal episodes in AHC [<xref ref-type="bibr" rid="rapid-odp.REF.sweney.2009.e534">Sweney et al 2009</xref>] include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Psychological stress</p>
            </list-item>
            <list-item>
              <p>Emotional excitement</p>
            </list-item>
            <list-item>
              <p>Environmental stressors: bright light (sunlight or fluorescent lighting), excessive heat or cold, or situations associated with excessive sound, crowds</p>
            </list-item>
            <list-item>
              <p>Water exposure in the form of bathing, swimming, shampooing</p>
            </list-item>
            <list-item>
              <p>Certain foods or odors: chocolate, food dyes, missed meals</p>
            </list-item>
            <list-item>
              <p>Excessive or atypically strenuous exercise (e.g., walking farther than usual, use of a playground swing)</p>
            </list-item>
            <list-item>
              <p>Illness</p>
            </list-item>
            <list-item>
              <p>Irregular sleep, missing a nap, delayed bedtime</p>
            </list-item>
          </list>
          <p><bold>CAPOS syndrome.</bold> Febrile illness can trigger an episode of ataxic encephalopathy and/or weakness.</p>
        </sec>
        <sec id="rapid-odp.Evaluation_of_Relatives_at_Ris">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="rapid-odp.Related_Genetic_Counseling_Iss">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="rapid-odp.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>The pregnancy of a woman should be monitored for symptoms of RDP, onset of which has followed childbirth in some (not all) women who are heterozygous for an <italic toggle="yes">ATP1A3</italic> pathogenic variant.</p>
          <p>In principle, abortion or caesarean section could be sufficiently stressful to also be a trigger.</p>
        </sec>
        <sec id="rapid-odp.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
        <sec id="rapid-odp.Other">
          <title>Other</title>
          <p>Levodopa and dopamine agonists usually provide little benefit, but are an important part of the diagnostic workup.</p>
          <p>There is no known way to prevent the abrupt onset of symptoms in RDP. During the abrupt onset, no acute treatment other than symptomatic relief of dystonia is available.</p>
        </sec>
      </sec>
      <sec id="rapid-odp.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="rapid-odp.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">ATP1A3</italic>-related neurologic disorders are inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="rapid-odp.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Many individuals diagnosed with RDP or CAPOS syndrome have an affected parent.</p>
            </list-item>
            <list-item>
              <p>A proband with an <italic toggle="yes">ATP1A3</italic>-related neurologic disorder may have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant.</p>
              <list list-type="bullet">
                <list-item>
                  <p><italic toggle="yes">De novo</italic> pathogenic variants are common in RDP: RDP resulted from <italic toggle="yes">de novo</italic> pathogenic variants in eight of 17 reported probands [<xref ref-type="bibr" rid="rapid-odp.REF.brashear.2007.828">Brashear et al 2007</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.kamm.2008.1501">Kamm et al 2008</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.anselm.2009.400">Anselm et al 2009</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.blancoarias.2009.2370">Blanco-Arias et al 2009</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.tarsy.2010.2213">Tarsy et al 2010</xref>].</p>
                </list-item>
                <list-item>
                  <p>AHC is usually the result of a <italic toggle="yes">de novo</italic> pathogenic variant.</p>
                </list-item>
                <list-item>
                  <p>CAPOS syndrome is known to have resulted from a <italic toggle="yes">de novo</italic> pathogenic variant in one of the three reported families (no samples were available to test for a <italic toggle="yes">de novo</italic> pathogenic variant in the other 2 families) and the simplex case [<xref ref-type="bibr" rid="rapid-odp.REF.demos.2014.15">Demos et al 2014</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.rosewich.2014a.133">Rosewich et al 2014a</xref>].</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant include obtaining a detailed medical and family history, examination by a movement disorder specialist, and molecular genetic testing of both parents for the <italic toggle="yes">ATP1A3</italic> pathogenic variant identified in the proband.</p>
            </list-item>
            <list-item>
              <p>Evaluation of parents may determine that one is affected but has escaped previous diagnosis because of a milder phenotypic presentation or reduced penetrance (reduced penetrance is seen in RDP but has not been reported in CAPOS syndrome; penetrance in AHC is currently unknown). Therefore, an apparently negative family history cannot be confirmed until appropriate evaluations and genetic testing have been performed.</p>
            </list-item>
          </list>
          <p>Note: If the parent is the individual in whom the pathogenic variant first occurred, s/he may have somatic mosaicism for the variant and may be mildly/minimally affected.</p>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband's parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of a proband is affected or has an <italic toggle="yes">ATP1A3</italic> pathogenic variant, the risk to the sibs of inheriting the pathogenic variant is 50%; however, the actual risk of being affected may be lower due to reduced penetrance in RDP and variable expressivity in CAPOS syndrome.</p>
            </list-item>
            <list-item>
              <p>Affected sibs usually share the same phenotypic features, although in one family reported, affected individuals were described as having typical and atypical AHC (i.e., intermediate phenotypes between AHC and RDP) [<xref ref-type="bibr" rid="rapid-odp.REF.roubergue.2013.1457">Roubergue et al 2013</xref>]. No families have been reported with typical AHC and typical RDP in different individuals have been reported.</p>
            </list-item>
            <list-item>
              <p>The sibs of a proband with clinically unaffected parents are still at increased risk for the disorder because of the possibility of reduced penetrance in a parent (RDP) and variable expressivity (CAPOS syndrome). Parents who are clinically unaffected should undergo molecular testing to determine if they have the <italic toggle="yes">ATP1A3</italic> pathogenic variant identified in the proband.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with RDP, AHC, or CAPOS syndrome has a 50% chance of inheriting the <italic toggle="yes">ATP1A3</italic> pathogenic variant identified in the proband.</p>
          <p>
            <bold>Other family members of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to other family members depends on the status of the proband's parents.</p>
            </list-item>
            <list-item>
              <p>If a parent is affected or has an <italic toggle="yes">ATP1A3</italic> pathogenic variant, his or her family members may be at risk.</p>
            </list-item>
          </list>
        </sec>
        <sec id="rapid-odp.Related_Genetic_Counseling_Iss">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Predictive testing</bold> for at-risk asymptomatic adult family members requires prior identification of the <italic toggle="yes">ATP1A3</italic> pathogenic variant in the family.</p>
          <p><bold>Issues unique to RDP.</bold> Because of the sudden onset of RDP, at-risk individuals may become hypervigilant about symptoms. Serious psychological issues have been observed in families [<xref ref-type="bibr" rid="rapid-odp.REF.brashear.2012a.1168">Brashear et al 2012a</xref>].</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has the pathogenic variant, the variant is likely <italic toggle="yes">de novo</italic>. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration can be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="rapid-odp.Prenatal_Testing_and_Preimplan">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">ATP1A3</italic> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for an <italic toggle="yes">ATP1A3</italic>-related neurologic disorder are possible.</p>
          <p>Requests for prenatal testing for conditions such as <italic toggle="yes">ATP1A3</italic>-related neurologic disorders are not common. Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="rapid-odp.Resources">
        <title>Resources</title>
      </sec>
      <sec id="rapid-odp.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="rapid-odp.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>The Na,K-ATPases convert metabolic energy by moving Na<sup>+</sup> ions out of the cell and K<sup>+</sup> ions into the cell, restoring the ion gradients reduced by the activity of ion channels and Na<sup>+</sup>-dependent carriers. In the central nervous system (CNS), the Na,K-ATPase is harnessed for reuptake of glutamate and other transmitters, extracellular K<sup>+</sup> buffering, extrusion of Ca<sup>2+</sup> by Na<sup>+</sup>:Ca<sup>2+</sup> exchange, and the regulation of cell volume. Because it transports three Na<sup>+</sup> ions out of the cell for every two K<sup>+</sup> ions transported in, it is electrogenic and makes a small direct hyperpolarizing contribution to membrane potential.</p>
          <p>Na,K-ATPase has three types of subunits (alpha, beta, and FXYD) and each subunit has multiple isoforms.</p>
          <list list-type="bullet">
            <list-item>
              <p>The catalytic alpha subunit has three isoforms (alpha 1, 2, and 3) that are expressed in the CNS by three distinct genes [<xref ref-type="bibr" rid="rapid-odp.REF.moseley.2003.5317">Moseley et al 2003</xref>]. Although it is found in a few peripheral cell types, the alpha 3 isoform is expressed exclusively in neurons in the CNS [<xref ref-type="bibr" rid="rapid-odp.REF.mcgrail.1991.381">McGrail et al 1991</xref>].</p>
            </list-item>
            <list-item>
              <p>Three beta subunits required for Na,K-ATPase function are also expressed in the CNS.</p>
            </list-item>
            <list-item>
              <p>The FXYD subunit regulates and modifies the properties of the complex; at least three FXYD subunits are expressed in the CNS.</p>
            </list-item>
          </list>
          <p>A recent review [<xref ref-type="bibr" rid="rapid-odp.REF.heinzen.2014.503">Heinzen et al 2014</xref>] includes information on animal models of rapid-onset dystonia-parkinsonism.</p>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">ATP1A3</italic> comprises 23 exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="rapid-odp" object-id="rapid-odp.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Benign variants.</bold> Several common coding SNPs are reported in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP">dbSNP</ext-link>.</p>
          <p>
            <bold>Pathogenic variants</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>RDP.</bold> To date, 14 missense or small indel variants have been described as causative of RDP in both familial cases and simplex cases (resulting from a <italic toggle="yes">de novo</italic> pathogenic variant) [reviewed in <xref ref-type="bibr" rid="rapid-odp.REF.heinzen.2014.503">Heinzen et al 2014</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.rosewich.2014b.945">Rosewich et al 2014b</xref>]. See <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="rapid-odp-Table2.pdf" content-type="local-data">Table 2</inline-supplementary-material> (pdf) for additional information.</p>
              <p>The variant c.2767G&#x0003e;A encoding p.Asp923Asn is the only pathogenic variant reported in both RDP and AHC. In one family, individuals with either AHC or RDP have been reported [<xref ref-type="bibr" rid="rapid-odp.REF.roubergue.2013.1457">Roubergue et al 2013</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>AHC.</bold> To date, pathogenic variants reported in individuals with the classic AHC phenotype are largely different from those reported with RDP; however, some overlap exists.</p>
              <p>More than 30 pathogenic variants have been reported to result in an AHC phenotype in more than 150 individuals. Most affected individuals have a <italic toggle="yes">de novo</italic> pathogenic variant; however, at least two familial cases with autosomal dominant inheritance have been reported as well as affected identical twins. Three pathogenic variants account for more than two thirds of the <italic toggle="yes">de novo</italic> variants observed to date [<xref ref-type="bibr" rid="rapid-odp.REF.heinzen.2012.1030">Heinzen et al 2012</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.rosewich.2012.764">Rosewich et al 2012</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.ishii.2013.e56120">Ishii et al 2013</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.roubergue.2013.1457">Roubergue et al 2013</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.hoeihansen.2014.50">Hoei-Hansen et al 2014</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.sasaki.2014a.153">Sasaki et al 2014a</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.ulatecampos.2014.377">Ulate-Campos et al 2014</xref>]. See <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="rapid-odp-Table2.pdf" content-type="local-data">Table 2</inline-supplementary-material> for additional information.</p>
            </list-item>
            <list-item>
              <p><bold>CAPOS syndrome.</bold> The ten individuals from three families with CAPOS syndrome and the single case resulting from a <italic toggle="yes">de novo</italic> pathogenic variant all have the same unique <italic toggle="yes">ATP1A3</italic> missense variant, p.Glu818Lys [<xref ref-type="bibr" rid="rapid-odp.REF.demos.2014.15">Demos et al 2014</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.rosewich.2014c.861">Rosewich et al 2014c</xref>].</p>
            </list-item>
          </list>
          <p><bold>Normal gene product.</bold>
<italic toggle="yes">ATP1A3</italic> encodes the alpha 3 subunit of the sodium/potassium-transporting ATPase (Na,K-ATPase), which comprises 1013 amino acid residues.</p>
          <p><bold>Abnormal gene product.</bold> Both functional studies and structural analysis of the alpha 3 subunit of the Na,K-ATPase suggest that pathogenic missense variants impair enzyme activity or stability [<xref ref-type="bibr" rid="rapid-odp.REF.de_carvalho_aguiar.2004.169">de Carvalho Aguiar et al 2004</xref>]; however, it is not known whether this loss of function occurs by haploinsufficiency or dominant-negative effects.</p>
          <p>Functional biochemical studies with several pathogenic variants associated with the RDP phenotype all show reduced Na<sup>+</sup> affinity suggesting that defects in the handling of Na<sup>+</sup> may be a major factor in the development and pathology of RDP [<xref ref-type="bibr" rid="rapid-odp.REF.rodacker.2006.18539">Rodacker et al 2006</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.blancoarias.2009.2370">Blanco-Arias et al 2009</xref>, <xref ref-type="bibr" rid="rapid-odp.REF.einholm.2010.26245">Einholm et al 2010</xref>].</p>
        </sec>
      </sec>
      <sec id="rapid-odp.References">
        <title>References</title>
        <sec id="rapid-odp.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="rapid-odp.Literature_Cited.reflist0">
            <ref id="rapid-odp.REF.ambrosini.2005.1826">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ambrosini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Onofrio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grieco</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Mambro</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montagna</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fortini</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicoletti</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nappi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sances</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schoenen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buzzi</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santorelli</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pierelli</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Familial basilar migraine associated with a new mutation in the ATP1A2 gene.</article-title>
                <source>Neurology</source>
                <volume>65</volume>
                <fpage>1826</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16344534</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.anselm.2009.400">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Anselm</surname>
                    <given-names>IA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sweadner</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gollamudi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozelius</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darras</surname>
                    <given-names>BT</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Rapid-onset dystonia-parkinsonism in a child with a novel atp1a3 gene mutation.</article-title>
                <source>Neurology</source>
                <volume>73</volume>
                <fpage>400</fpage>
                <lpage>1</lpage>
                <pub-id pub-id-type="pmid">19652145</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.bassi.2004.621">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bassi</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bresolin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonelli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nazos</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crippa</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baschirotto</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zucca</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bersano</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dolcetta</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boneschi</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barone</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casari</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>A novel mutation in the ATP1A2 gene causes alternating hemiplegia of childhood.</article-title>
                <source>J Med Genet.</source>
                <volume>41</volume>
                <fpage>621</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15286158</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.blancoarias.2009.2370">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Blanco-Arias</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Einholm</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mamsa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Concheiro</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guti&#x000e9;rrez-de-Ter&#x000e1;n</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romero</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toustrup-Jensen</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carracedo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jen</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilsen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobrido</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>A C-terminal mutation of ATP1A3 underscores the crucial role of sodium affinity in the pathophysiology of rapid-onset dystonia-parkinsonism.</article-title>
                <source>Hum.Mol Genet.</source>
                <volume>18</volume>
                <fpage>2370</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">19351654</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.brashear.1998a.521">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brashear</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Butler</surname>
                    <given-names>IJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hyland</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farlow</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobyns</surname>
                    <given-names>WB</given-names>
                  </name>
                </person-group>
                <year>1998a</year>
                <article-title>Cerebrospinal fluid homovanillic acid levels in rapid-onset dystonia-parkinsonism.</article-title>
                <source>Ann Neurol.</source>
                <volume>43</volume>
                <fpage>521</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9546335</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.brashear.1998b.335">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brashear</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Butler</surname>
                    <given-names>IJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozelius</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kramer</surname>
                    <given-names>PI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farlow</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breakefield</surname>
                    <given-names>XO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobyns</surname>
                    <given-names>WB</given-names>
                  </name>
                </person-group>
                <year>1998b</year>
                <article-title>Rapid-onset dystonia-parkinsonism: a report of clinical, biochemical, and genetic studies in two families.</article-title>
                <source>Adv Neurol.</source>
                <volume>78</volume>
                <fpage>335</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9750930</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.brashear.2012a.1168">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brashear</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cook</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amponsah</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snively</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Light</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boggs</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suerken</surname>
                    <given-names>CK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stacy</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozelius</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sweadner</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCall</surname>
                    <given-names>WV</given-names>
                  </name>
                </person-group>
                <year>2012a</year>
                <article-title>Psychiatric disorders in rapid-onset dystonia-parkinsonism.</article-title>
                <source>Neurology</source>
                <volume>79</volume>
                <fpage>1168</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">22933743</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.brashear.1997.1066">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brashear</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeLeon</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bressman</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thyagarajan</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farlow</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobyns</surname>
                    <given-names>WB</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Rapid-onset dystonia-parkinsonism in a second family.</article-title>
                <source>Neurology</source>
                <volume>48</volume>
                <fpage>1066</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9109901</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.brashear.2007.828">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brashear</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobyns</surname>
                    <given-names>WB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Carvalho Aguiar</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borg</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frijns</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gollamudi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guimaraes</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haake</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linazasoro</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munchau</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raymond</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riley</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saunders-Pullman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tijssen</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Webb</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zaremba</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bressman</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozelius</surname>
                    <given-names>LJ</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>The phenotypic spectrum of rapid-onset dystonia-parkinsonism (RDP) and mutations in the ATP1A3 gene.</article-title>
                <source>Brain</source>
                <volume>130</volume>
                <fpage>828</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">17282997</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.brashear.1996.151">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brashear</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farlow</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Butler</surname>
                    <given-names>IJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kasarskis</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobyns</surname>
                    <given-names>WB</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Variable phenotype of rapid-onset dystonia-parkinsonism.</article-title>
                <source>Mov Disord.</source>
                <volume>11</volume>
                <fpage>151</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">8684384</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.brashear.2012b.1065">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brashear</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mink</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boggs</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCall</surname>
                    <given-names>WV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stacy</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snively</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Light</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sweadner</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozelius</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morrison</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2012b</year>
                <article-title>ATP1A3 mutations in infants: a new rapid-onset dystonia-parinsonism phenotype characterized by motor delay and ataxia.</article-title>
                <source>Dev Med Child Neurol.</source>
                <volume>54</volume>
                <fpage>1065</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">22924536</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.brashear.1999.132">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brashear</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulholland</surname>
                    <given-names>GK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zheng</surname>
                    <given-names>QH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farlow</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siemers</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hutchins</surname>
                    <given-names>GD</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>PET imaging of the pre-synaptic dopamine uptake sites in rapid-onset dystonia-parkinsonism (RDP).</article-title>
                <source>Mov Disord.</source>
                <volume>14</volume>
                <fpage>132</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9918356</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.bressman.2002.1780">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bressman</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raymond</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wendt</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saunders-Pullman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Leon</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fahn</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozelius</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Risch</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Diagnostic criteria for dystonia in DYT1 families.</article-title>
                <source>Neurology</source>
                <volume>59</volume>
                <fpage>1780</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">12473770</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.chi.2012.506">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chi</surname>
                    <given-names>LY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>XH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>XW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chi</surname>
                    <given-names>ZF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>SJ</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Alternating hemiplegia of childhood in chinese following long-term treatment with flunarizine or topiramate.</article-title>
                <source>Int J Neurosci</source>
                <volume>122</volume>
                <fpage>506</fpage>
                <lpage>510</lpage>
                <pub-id pub-id-type="pmid">22494152</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.cook.2014.344">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cook</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snively</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boggs</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suerken</surname>
                    <given-names>CK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haq</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stacy</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCall</surname>
                    <given-names>WV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozelius</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sweadner</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brashear</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Cognitive impairment in rapid-onset dystonia-parkinsonism.</article-title>
                <source>Mov Disord.</source>
                <year>2014</year>
                <month>Mar</month>
                <volume>29</volume>
                <issue>3</issue>
                <fpage>344</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">24436111</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.dangond.1997.35">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dangond</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garada</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murawski</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rey-Casserly</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holman</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mikati</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Focal brain dysfunction in a 41-year old man with familial alternating hemiplegia.</article-title>
                <source>Eur Arch Psychiatry Clin Neurosci.</source>
                <volume>247</volume>
                <fpage>35</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">9088804</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.de_carvalho_aguiar.2004.169">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>de Carvalho Aguiar</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sweadner</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Penniston</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zaremba</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caton</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linazasoro</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borg</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tijssen</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bressman</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobyns</surname>
                    <given-names>WB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brashear</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozelius</surname>
                    <given-names>LJ</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Mutations in the Na+/K+ -ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism.</article-title>
                <source>Neuron</source>
                <volume>43</volume>
                <fpage>169</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">15260953</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.de_fusco.2003.192">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Fusco</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marconi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silvestri</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atorino</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rampoldi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgante</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ballabio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aridon</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casari</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2.</article-title>
                <source>Nat Genet</source>
                <volume>33</volume>
                <fpage>192</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">12539047</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.demos.2014.15">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Demos</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Karnebeek</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adam</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhan</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shyr</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horvath</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suri</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fryer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedman</surname>
                    <given-names>JM</given-names>
                  </name>
                  <collab>FORGE Canada Consortium</collab>
                </person-group>
                <article-title>A novel recurrent mutation in ATP1A3 causes CAPOS syndrome.</article-title>
                <source>Orphanet J Rare Dis.</source>
                <year>2014</year>
                <volume>9</volume>
                <fpage>15</fpage>
                <pub-id pub-id-type="pmid">24468074</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.dobyns.1993.2596">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dobyns</surname>
                    <given-names>WB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozelius</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kramer</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brashear</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farlow</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perry</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walsh</surname>
                    <given-names>LE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kasarskis</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Butler</surname>
                    <given-names>IJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breakefield</surname>
                    <given-names>XO</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Rapid-onset dystonia-parkinsonism.</article-title>
                <source>Neurology</source>
                <volume>43</volume>
                <fpage>2596</fpage>
                <lpage>602</lpage>
                <pub-id pub-id-type="pmid">8255463</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.einholm.2010.26245">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Einholm</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toustrup-Jensen</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holm</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andersen</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilsen</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>The rapid-onset dystonia parkinsonism mutation D923N of the Na+, K+-ATPase alpha3 isoform disrupts Na+ interaction at the third Na+ site.</article-title>
                <source>J Biol Chem.</source>
                <volume>285</volume>
                <fpage>26245</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">20576601</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.geyer.2006.780">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Geyer</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bressman</surname>
                    <given-names>SB</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>The diagnosis of dystonia.</article-title>
                <source>Lancet Neurol</source>
                <volume>5</volume>
                <fpage>780</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">16914406</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.heinzen.2014.503">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Heinzen</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arzimanoglou</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brashear</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clapcote</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gurrieri</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldstein</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>J&#x000f3;hannesson</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mikati</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neville</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicole</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozelius</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poulsen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schyns</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sweadner</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Maagdenberg</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Vilsen B for the ATP1A3 Working Group. Distinct neurological disorders with ATP1A3 mutations.</article-title>
                <source>Lancet Neurol.</source>
                <year>2014</year>
                <volume>13</volume>
                <fpage>503</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">24739246</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.heinzen.2012.1030">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Heinzen</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swoboda</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hitomi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gurrieri</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicole</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vries</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tiziano</surname>
                    <given-names>FD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fontaine</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walley</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heavin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Panagiotakaki</surname>
                    <given-names>E</given-names>
                  </name>
                  <etal/>
                </person-group>
                <article-title>De novo mutations in ATP1A3 cause alternating hemiplegia of childhood.</article-title>
                <source>Nat Genet.</source>
                <year>2012</year>
                <volume>44</volume>
                <fpage>1030</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">22842232</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.hoeihansen.2014.50">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hoei-Hansen</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dali</surname>
                    <given-names>C&#x000cd;</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyngbye</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duno</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uldall</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Alternating hemiplegia of childhood in Denmark: clinical manifestations and ATP1A3 mutation status.</article-title>
                <source>Eur J Paediatr Neurol.</source>
                <volume>18</volume>
                <fpage>50</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">24100174</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.ishii.2013.e56120">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ishii</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitsui</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishiura</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshimura</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arai</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamashita</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimura</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oguni</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morishita</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuji</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirose</surname>
                    <given-names>S.</given-names>
                  </name>
                </person-group>
                <article-title>Identification of ATP1A3 mutations by exome sequencing as the cause of alternating hemiplegia of childhood in Japanese patients.</article-title>
                <source>PLoS One.</source>
                <year>2013</year>
                <volume>8</volume>
                <issue>2</issue>
                <fpage>e56120</fpage>
                <pub-id pub-id-type="pmid">23409136</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.jen.2007.523">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jen</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boltshauser</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cartwright</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roach</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mamsa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baloh</surname>
                    <given-names>RW</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Prolonged hemiplegic episodes in children due to mutations in ATP1A2.</article-title>
                <source>J Neurol Neurosurg Psychiatry.</source>
                <volume>78</volume>
                <fpage>523</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17435187</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.jen.2005.529">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jen</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palos</surname>
                    <given-names>TP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howard</surname>
                    <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baloh</surname>
                    <given-names>RW</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Mutation in the glutamate transporter EAAT1 causes episodic ataxia,&#x000a0;hemiplegia, and seizures.</article-title>
                <source>Neurology.</source>
                <volume>65</volume>
                <fpage>529</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">16116111</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.jiang.2006.229">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chi</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ma</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Du</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shang</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Topiramate: a new agent for patients with alternating hemiplegia of childhood.</article-title>
                <source>Neuropediatrics</source>
                <volume>37</volume>
                <fpage>229</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">17177149</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.kabakci.2005.860">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kabakci</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isbruch</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schilling</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hedrich</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Carvalho Aguiar</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozelius</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kramer</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwarz</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Genetic heterogeneity in rapid onset dystonia-parkinsonism: description of a new family.</article-title>
                <source>J Neurol Neurosurg Psychiatry</source>
                <volume>76</volume>
                <fpage>860</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">15897512</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.kamm.2008.1501">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kamm</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fogel</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>W&#x000e4;chter</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schweitzer</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berg</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kruger</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freudenstein</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasser</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Novel ATP1A3 mutation in a sporadic RDP patient with minimal benefit from deep brain stimulation.</article-title>
                <source>Neurology</source>
                <volume>70</volume>
                <fpage>1501</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">18413579</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.kamphuis.2006.118">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kamphuis</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koelman</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lees</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tijssen</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Sporadic rapid-onset dystonia-parkinsonism presenting as Parkinson's disease.</article-title>
                <source>Mov Disord.</source>
                <volume>21</volume>
                <fpage>118</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16161139</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.kansagra.2013.821">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kansagra</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mikati</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vigevano</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Alternating hemiplegia of childhood.</article-title>
                <source>Handb Clin Neurol.</source>
                <year>2013</year>
                <volume>112</volume>
                <fpage>821</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">23622289</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.kaunisto.2004.141">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kaunisto</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harno</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanmolkot</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gargus</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamalainen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liukkonen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kallela</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Maagdenberg</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frants</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farkkila</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palotie</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wessman</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>A novel missense ATP1A2 mutation in a Finnish family with familial hemiplegic migraine type 2.</article-title>
                <source>Neurogenetics</source>
                <volume>5</volume>
                <fpage>141</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15133718</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.kim.2013.440">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lim</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chae</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>SK</given-names>
                  </name>
                </person-group>
                <article-title>Low incidence of SCN1A genetic mutation in patients with hemiconvulsion-hemiplegia-epilepsy syndrome.</article-title>
                <source>Epilepsy Res.</source>
                <year>2013</year>
                <volume>106</volume>
                <fpage>440</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">23916143</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.kr_geloh.1980.784">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kr&#x000e4;geloh</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aicardi</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Alternating hemiplegia in infants: report of five cases.</article-title>
                <source>Dev Med Child Neurol.</source>
                <year>1980</year>
                <month>Dec</month>
                <volume>22</volume>
                <issue>6</issue>
                <fpage>784</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">7450304</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.kramer.1999.176">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kramer</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mineta</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schilling</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Leon</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farlow</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breakefield</surname>
                    <given-names>XO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bressman</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobyns</surname>
                    <given-names>WB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozelius</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brashear</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Rapid-onset dystonia-parkinsonism: linkage to chromosome 19q13.</article-title>
                <source>Ann.Neurol.</source>
                <volume>46</volume>
                <fpage>176</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">10443882</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.lee.2007.1808">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gollamudi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozelius</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeon</surname>
                    <given-names>BS</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>ATP1A3 mutation in the first Asian case of rapid-onset dystonia-parkinsonism.</article-title>
                <source>Mov Disord.</source>
                <volume>22</volume>
                <fpage>1808</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17595045</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.linazasoro.2002.608">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Linazasoro</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Indakoetxea</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruiz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Blercom</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lasa</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Possible sporadic rapid-onset dystonia-parkinsonism.</article-title>
                <source>Mov Disord.</source>
                <volume>17</volume>
                <fpage>608</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12112218</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.mcgrail.1991.381">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McGrail</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phillips</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sweadner</surname>
                    <given-names>KJ</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Immunofluorescent localization of three Na,K-ATPase isozymes in the rat central nervous system: both neurons and glia can express more than one Na,K-ATPase.</article-title>
                <source>J.Neurosci.</source>
                <volume>11</volume>
                <fpage>381</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">1846906</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.mckeon.2007.1325">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McKeon</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozelius</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hardiman</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenway</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pittock</surname>
                    <given-names>SJ</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Heterogeneity of presentation and outcome in the Irish rapid-onset dystonia-Parkinsonism kindred.</article-title>
                <source>Mov Disord.</source>
                <volume>22</volume>
                <fpage>1325</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17516473</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.moseley.2003.5317">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moseley</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lieske</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wetzel</surname>
                    <given-names>RK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>James</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shelly</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paul</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boivin</surname>
                    <given-names>GP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Witte</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramirez</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sweadner</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lingrel</surname>
                    <given-names>JB</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>The Na,K-ATPase alpha 2 isoform is expressed in neurons, and its absence disrupts neuronal activity in newborn mice.</article-title>
                <source>J Biol Chem.</source>
                <volume>278</volume>
                <fpage>5317</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">12458206</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.neville.2007.777">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Neville</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ninan</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>The treatment and management of alternating hemiplegia of childhood.</article-title>
                <source>Dev Med Child Neurol.</source>
                <volume>49</volume>
                <fpage>777</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">17880649</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.nicolaides.1996.419">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nicolaides</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Appleton</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fryer</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS): a new syndrome.</article-title>
                <source>J Med Genet.</source>
                <volume>33</volume>
                <fpage>419</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">8733056</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.nygaard.1994.236">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nygaard</surname>
                    <given-names>TG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waran</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levine</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naini</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chutorian</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>Dopa-responsive dystonia simulating cerebral palsy.</article-title>
                <source>Pediatr. Neurol</source>
                <volume>11</volume>
                <fpage>236</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">7880338</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.oblak.2014.81">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oblak</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hagen</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sweadner</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haq</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whitlow</surname>
                    <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maldjian</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Epperson</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cook</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stacy</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murrell</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozelius</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brashear</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghetti</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>Rapid-onset dystonia-parkinsonism associated with the I758S mutation of the ATP1A3 gene: a neuropathologic and neuroanatomical study of four siblings.</article-title>
                <source>Acta Neuropathol.</source>
                <year>2014</year>
                <month>Jul</month>
                <volume>128</volume>
                <issue>1</issue>
                <fpage>81</fpage>
                <lpage>98</lpage>
                <pub-id pub-id-type="pmid">24803225</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.panagiotakaki.2010.3598">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Panagiotakaki</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gobbi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neville</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ebinger</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campistol</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nevs&#x000ed;malov&#x000e1;</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laan</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casaer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spiel</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giannotta</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fons</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ninan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sange</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schyns</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vavassori</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poncelin</surname>
                    <given-names>D</given-names>
                  </name>
                  <collab>ENRAH Consortium</collab>
                </person-group>
                <article-title>Arzimanoglou A. Evidence of a non-progressive course of alternating hemiplegia of childhood: study of a large cohort of children and adults.</article-title>
                <source>Brain.</source>
                <year>2010</year>
                <month>Dec</month>
                <volume>133</volume>
                <issue>Pt 12</issue>
                <fpage>3598</fpage>
                <lpage>610</lpage>
                <pub-id pub-id-type="pmid">20974617</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.pekmezovic.2009.161">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pekmezovic</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Svetel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ivanovic</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dragasevic</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petrovic</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tepavcevic</surname>
                    <given-names>DK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kostic</surname>
                    <given-names>VS</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Quality of life in patients with focal dystonia.</article-title>
                <source>Clin Neurol Neurosurg.</source>
                <volume>111</volume>
                <fpage>161</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">18995953</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.pittock.2000.991">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pittock</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joyce</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Keane</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hugle</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hardiman</surname>
                    <given-names>MO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brett</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barton</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>King</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Webb</surname>
                    <given-names>DW</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Rapid-onset dystonia-parkinsonism: a clinical and genetic analysis of a new kindred.</article-title>
                <source>Neurology</source>
                <volume>55</volume>
                <fpage>991</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">11061257</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.rodacker.2006.18539">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rodacker</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toustrup-Jensen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilsen</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Mutations Phe785Leu and Thr618Met in Na+,K+-ATPase, associated with familial rapid-onset dystonia parkinsonism, interfere with Na+ interaction by distinct mechanisms.</article-title>
                <source>J Biol Chem.</source>
                <volume>281</volume>
                <fpage>18539</fpage>
                <lpage>48</lpage>
                <pub-id pub-id-type="pmid">16632466</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.rosewich.2014a.133">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rosewich</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baethmann</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohlenbusch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000e4;rtner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brockmann</surname>
                    <given-names>K.</given-names>
                  </name>
                </person-group>
                <article-title>A novel ATP1A3 mutation with unique clinical presentation.</article-title>
                <source>J Neurol Sci.</source>
                <year>2014a</year>
                <volume>341</volume>
                <fpage>133</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">24713507</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.rosewich.2014b.945">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rosewich</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohlenbusch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huppke</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlotawa</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baethmann</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrilho</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fiori</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Louren&#x000e7;o</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sawyer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinfeld</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000e4;rtner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brockmann</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>The expanding clinical and genetic spectrum of ATP1A3-related disorder.</article-title>
                <source>Neurology.</source>
                <year>2014b</year>
                <volume>82</volume>
                <fpage>945</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">24523486</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.rosewich.2012.764">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rosewich</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thiele</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohlenbusch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maschke</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Altm&#x000fc;ller</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frommolt</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zirn</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ebinger</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siemes</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>N&#x000fc;rnberg</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brockmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000e4;rtner</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Heterozygous de-novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood: a whole-exome sequencing gene-identification study.</article-title>
                <source>Lancet Neurol.</source>
                <year>2012</year>
                <volume>11</volume>
                <fpage>764</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">22850527</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.rosewich.2014c.861">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rosewich</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weise</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohlenbusch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000e4;rtner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brockmann</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Phenotypic overlap of alternating hemiplegia of childhood and CAPOS syndrome.</article-title>
                <source>Neurology.</source>
                <year>2014c</year>
                <volume>83</volume>
                <fpage>861</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">25056583</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.rotstein.2009.2042">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rotstein</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doran</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ullner</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelstad</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Glut1 deficiency and alternating hemiplegia of childhood.</article-title>
                <source>Neurology.</source>
                <volume>73</volume>
                <fpage>2042</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">19996082</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.roubergue.2015.7">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Roubergue</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philibert</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gautier</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuster</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markowicz</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Billette de Villemeur</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vuillaumier-Barrot</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicole</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roze</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doummar</surname>
                    <given-names>D.</given-names>
                  </name>
                </person-group>
                <article-title>Excellent response to a ketogenic diet in a patient with alternating hemiplegia of childhood.</article-title>
                <source>JIMD Rep.</source>
                <year>2015</year>
                <volume>15</volume>
                <fpage>7</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">24532324</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.roubergue.2013.1457">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Roubergue</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roze</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vuillaumier-Barrot</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fontenille</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000e9;neret</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vidailhet</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fontaine</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doummar</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philibert</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riant</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicole</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>The multiple faces of the ATP1A3-related dystonic movement disorder.</article-title>
                <source>Mov Disord.</source>
                <year>2013</year>
                <volume>28</volume>
                <fpage>1457</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">23483595</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.sasaki.2001.303">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Long-term effect of flunarizine on patients with alternating hemiplegia of childhood in Japan.</article-title>
                <source>Brain Dev.</source>
                <volume>23</volume>
                <fpage>303</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">11504600</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.sasaki.2014a.153">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishii</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirose</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2014a</year>
                <article-title>Intermediate form between alternating hemipegia of childhood and rapid-onset dystonia-parkinsonism.</article-title>
                <source>Mov Disord</source>
                <volume>29</volume>
                <fpage>153</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">24123283</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.sasaki.2014b.482">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishii</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morisada</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iijima</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takada</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Araki</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanabe</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arai</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamashita</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohashi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oda</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ichiseki</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirabayashi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yasuhara</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawawaki</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimura</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimono</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narumiya</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshida</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oyazato</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuneishi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozasa</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yokochi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dejima</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akiyama</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kishi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kira</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikeda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oguni</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuji</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirose</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2014b</year>
                <article-title>Genotype-phenotype correlations in alternating hemiplegia of childhood.</article-title>
                <source>Neurology.</source>
                <volume>82</volume>
                <fpage>482</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">24431296</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.silver.1993.36">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Silver</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Alternating hemiplegia of childhood: a study of 10 patients and results of flunarizine treatment.</article-title>
                <source>Neurology.</source>
                <volume>43</volume>
                <fpage>36</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">8423908</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.svetel.2010.472">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Svetel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozelius</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buckley</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lohmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brajkovi&#x00107;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kosti&#x00107;</surname>
                    <given-names>VS</given-names>
                  </name>
                </person-group>
                <article-title>Rapid-onset dystonia-parkinsonism: case report.</article-title>
                <source>J Neurol.</source>
                <year>2010</year>
                <volume>257</volume>
                <fpage>472</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">19936820</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.sweney.2009.e534">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sweney</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silver</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerard-Blanluet</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pedespan</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Renault</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arzimanoglou</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlesinger-Massart</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewelt</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reyna</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swoboda</surname>
                    <given-names>KJ</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Alternating hemiplegia of childhood: early characteristics and evolution of a neurodevelopmental syndrome.</article-title>
                <source>Pediatrics.</source>
                <volume>123</volume>
                <fpage>e534</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">19254988</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.swoboda.2004.884">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Swoboda</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanavakis</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xaidara</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leppert</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlesinger-Massart</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ptacek</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silver</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Youroukos</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Alternating hemiplegia of childhood or familial hemiplegic migraine? A novel ATP1A2 mutation.</article-title>
                <source>Ann Neurol.</source>
                <volume>55</volume>
                <fpage>884</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15174025</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.tarsy.2010.2213">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tarsy</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sweadner</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>PC</given-names>
                  </name>
                </person-group>
                <article-title>Case records of the Massachusetts General Hospital. Case 17-2010 - A 29-year-old woman with flexion of the left hand and foot and difficulty speaking.</article-title>
                <source>N Engl J Med.</source>
                <year>2010</year>
                <volume>362</volume>
                <fpage>2213</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">20558373</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.todt.2005.315">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Todt</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dichgans</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jurkat-Rott</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heinze</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zifarelli</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koenderink</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goebel</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zumbroich</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stiller</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramirez</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedrich</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gobel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kubisch</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Rare missense variants in ATP1A2 in families with clustering of common forms of migraine.</article-title>
                <source>Hum Mutat.</source>
                <volume>26</volume>
                <fpage>315</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">16110494</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.ulatecampos.2014.377">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ulate-Campos</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fons</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Artuch</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castej&#x000f3;n</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martorell</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozelius</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pascual</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campistol</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Alternating hemiplegia of childhood with a de novo mutation in ATP1A3 and changes in SLC2A1 to a ketogenic diet.</article-title>
                <source>Pediatr Neurol.</source>
                <year>2014</year>
                <volume>50</volume>
                <fpage>377</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">24491413</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.vanmolkot.2003.360">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vanmolkot</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kors</surname>
                    <given-names>EE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hottenga</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terwindt</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoefnagels</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Black</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sandkuijl</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frants</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Maagdenberg</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Novel mutations in the Na+, K+-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions.</article-title>
                <source>Ann Neurol.</source>
                <volume>54</volume>
                <fpage>360</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">12953268</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.verret.1971.675">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Verret</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steele</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <year>1971</year>
                <article-title>Alternating hemiplegia in childhood: a report of eight patients with complicated migraine beginning in infancy.</article-title>
                <source>Pediatrics.</source>
                <volume>47</volume>
                <fpage>675</fpage>
                <lpage>680</lpage>
                <pub-id pub-id-type="pmid">5089756</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.webb.1999.171">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Webb</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Broderick</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brashear</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobyns</surname>
                    <given-names>WB</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Rapid onset dystonia-parkinsonism in a 14-year-old girl.</article-title>
                <source>Eur J Paediatr Neurol.</source>
                <volume>3</volume>
                <fpage>171</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">10476366</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.weller.2014.1062">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Weller</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pelzer</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vries</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f3;pez</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De F&#x000e0;bregues</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pascual</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arroyo</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koelewijn</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stam</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terwindt</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Maagdenberg</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <article-title>Two novel SCN1A mutations identified in families with familial hemiplegic migraine.</article-title>
                <source>Cephalalgia.</source>
                <year>2014</year>
                <volume>34</volume>
                <fpage>1062</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">24707016</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.zanottifregonara.2008.148">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zanotti-Fregonara</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vidailhet</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kas</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozelius</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clot</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hindi&#x000e9;</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ravasi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devaux</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roze</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>[123I]-FP-CIT and [99mTc]-HMPAO single photon emission computed tomography in a new sporadic case of rapid-onset dystonia-parkinsonism.</article-title>
                <source>J Neurol Sci.</source>
                <volume>273</volume>
                <fpage>148</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">18675996</pub-id>
              </element-citation>
            </ref>
            <ref id="rapid-odp.REF.zaremba.2004.1506">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zaremba</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mierzewska</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lysiak</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kramer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozelius</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brashear</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Rapid-onset dystonia-parkinsonism: a fourth family consistent with linkage to chromosome 19q13.</article-title>
                <source>Mov Disord.</source>
                <volume>19</volume>
                <fpage>1506</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">15390049</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="rapid-odp.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="rapid-odp.Author_Notes">
          <title>Author Notes</title>
          <p>
            <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://rdpstudy.phs.wakehealth.edu/public/homepage.html">
              <bold>RDP Study</bold>
            </ext-link>
          </p>
          <p>To obtain up-to-date help, a report of possible diagnosis should be made to one of the AHC or RDP organizations listed above under <xref ref-type="sec" rid="rapid-odp.Resources">Resources</xref>. There, contacts with experienced clinicians can be found as well as information about known pathogenic variants; and novel pathogenic variants can be considered. For AHC, there are parent organizations in several countries that provide advice and support, raise funding for research, and hold family meetings.</p>
          <p>Novel variants and novel symptoms associated with <italic toggle="yes">ATP1A3</italic> variants should also be reported to these organizations. The identification of non-pathogenic genetic variants is also possible in patients with other disease etiologies, and is important to arrive at a correct diagnosis. Equally important are reports of patients with typical manifestations but without a pathogenic variant in <italic toggle="yes">ATP1A3</italic>, who might have a pathogenic variant in a second causative gene.</p>
        </sec>
        <sec id="rapid-odp.Acknowledgments">
          <title>Acknowledgments</title>
          <p>The authors would like to thank Dr William B Dobyns for his contributions to this research and all of the families and patients who participated in this research.</p>
        </sec>
        <sec id="rapid-odp.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>6 November 2014 (me) Comprehensive update posted live; title changed</p>
            </list-item>
            <list-item>
              <p>13 September 2012 (ab/tb) Revision: alternating hemiplegia of childhood added as a genetically related disorder</p>
            </list-item>
            <list-item>
              <p>25 August 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>19 March 2009 (cd) Revision: sequence analysis available clinically</p>
            </list-item>
            <list-item>
              <p>7 February 2008 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>5 October 2007 (ab) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
